BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Recklies AD, White C, Ling H. The chitinase 3-like protein human cartilage glycoprotein 39 (HC-gp39) stimulates proliferation of human connective-tissue cells and activates both extracellular signal-regulated kinase- and protein kinase B-mediated signalling pathways. Biochem J. 2002;365:119-126. [PMID: 12071845 DOI: 10.1042/bj20020075] [Cited by in Crossref: 264] [Cited by in F6Publishing: 243] [Article Influence: 13.9] [Reference Citation Analysis]
Number Citing Articles
1 Syder AJ, Oh JD, Guruge JL, O'Donnell D, Karlsson M, Mills JC, Björkholm BM, Gordon JI. The impact of parietal cells on Helicobacter pylori tropism and host pathology: an analysis using gnotobiotic normal and transgenic mice. Proc Natl Acad Sci U S A 2003;100:3467-72. [PMID: 12629225 DOI: 10.1073/pnas.0230380100] [Cited by in Crossref: 47] [Cited by in F6Publishing: 44] [Article Influence: 2.6] [Reference Citation Analysis]
2 Matsuura H, Hartl D, Kang MJ, Dela Cruz CS, Koller B, Chupp GL, Homer RJ, Zhou Y, Cho WK, Elias JA, Lee CG. Role of breast regression protein-39 in the pathogenesis of cigarette smoke-induced inflammation and emphysema. Am J Respir Cell Mol Biol 2011;44:777-86. [PMID: 20656949 DOI: 10.1165/rcmb.2010-0081OC] [Cited by in Crossref: 48] [Cited by in F6Publishing: 32] [Article Influence: 4.4] [Reference Citation Analysis]
3 Di Rosa M, Tibullo D, Vecchio M, Nunnari G, Saccone S, Di Raimondo F, Malaguarnera L. Determination of chitinases family during osteoclastogenesis. Bone. 2014;61:55-63. [PMID: 24440516 DOI: 10.1016/j.bone.2014.01.005] [Cited by in Crossref: 33] [Cited by in F6Publishing: 33] [Article Influence: 4.7] [Reference Citation Analysis]
4 Kjaergaard AD, Johansen JS, Bojesen SE, Nordestgaard BG. Role of inflammatory marker YKL-40 in the diagnosis, prognosis and cause of cardiovascular and liver diseases. Crit Rev Clin Lab Sci 2016;53:396-408. [PMID: 27187575 DOI: 10.1080/10408363.2016.1190683] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 4.6] [Reference Citation Analysis]
5 Nielsen AR, Plomgaard P, Krabbe KS, Johansen JS, Pedersen BK. IL-6, but not TNF-α, increases plasma YKL-40 in human subjects. Cytokine. 2011;55:152-155. [PMID: 21478032 DOI: 10.1016/j.cyto.2011.03.014] [Cited by in Crossref: 60] [Cited by in F6Publishing: 58] [Article Influence: 6.0] [Reference Citation Analysis]
6 Antonelli M, Massimino M, Morra I, Garrè ML, Gardiman MP, Buttarelli FR, Arcella A, Giangaspero F. Expression of pERK and pAKT in pediatric high grade astrocytomas: correlation with YKL40 and prognostic significance. Neuropathology 2012;32:133-8. [PMID: 21978279 DOI: 10.1111/j.1440-1789.2011.01252.x] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 1.9] [Reference Citation Analysis]
7 Shao R. YKL-40 acts as an angiogenic factor to promote tumor angiogenesis. Front Physiol 2013;4:122. [PMID: 23755018 DOI: 10.3389/fphys.2013.00122] [Cited by in Crossref: 57] [Cited by in F6Publishing: 59] [Article Influence: 7.1] [Reference Citation Analysis]
8 Rehli M, Niller HH, Ammon C, Langmann S, Schwarzfischer L, Andreesen R, Krause SW. Transcriptional regulation of CHI3L1, a marker gene for late stages of macrophage differentiation. J Biol Chem. 2003;278:44058-44067. [PMID: 12933821 DOI: 10.1074/jbc.m306792200] [Cited by in Crossref: 152] [Cited by in F6Publishing: 68] [Article Influence: 8.4] [Reference Citation Analysis]
9 Lian C, Lou H, Zhang J, Tian H, Ou Q, Xu JY, Jin C, Gao F, Zhang J, Wang J, Li W, Xu G, Lu L, Xu GT. MicroRNA-24 protects retina from degeneration in rats by down-regulating chitinase-3-like protein 1. Exp Eye Res 2019;188:107791. [PMID: 31491426 DOI: 10.1016/j.exer.2019.107791] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
10 Antonelli M, Buttarelli FR, Arcella A, Nobusawa S, Donofrio V, Oghaki H, Giangaspero F. Prognostic significance of histological grading, p53 status, YKL-40 expression, and IDH1 mutations in pediatric high-grade gliomas. J Neurooncol 2010;99:209-15. [PMID: 20174854 DOI: 10.1007/s11060-010-0129-5] [Cited by in Crossref: 50] [Cited by in F6Publishing: 49] [Article Influence: 4.5] [Reference Citation Analysis]
11 Zheng M, Wu YJ, Cai WM, Weng HL, Liu RH. Construction of a hepatic stellate cells subtracted cDNA library of differentially expressed genes in normal mice and mice with Schistosomiasis japonica. J Zhejiang Univ Sci B 2005;6:280-7. [PMID: 15754426 DOI: 10.1631/jzus.2005.B0280] [Reference Citation Analysis]
12 Rivera AL, Pelloski CE. Diagnostic and prognostic molecular markers in common adult gliomas. Expert Review of Molecular Diagnostics 2014;10:637-49. [DOI: 10.1586/erm.10.44] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
13 Park SJ, Jun YJ, Kim TH, Jung JY, Hwang GH, Jung KJ, Lee SH, Lee HM, Lee SH. Increased expression of YKL-40 in mild and moderate/severe persistent allergic rhinitis and its possible contribution to remodeling of nasal mucosa. Am J Rhinol Allergy 2013;27:372-80. [PMID: 24119600 DOI: 10.2500/ajra.2013.27.3941] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 3.0] [Reference Citation Analysis]
14 Ringsholt M, Høgdall EV, Johansen JS, Price PA, Christensen LH. YKL-40 protein expression in normal adult human tissues--an immunohistochemical study. J Mol Histol 2007;38:33-43. [PMID: 17242979 DOI: 10.1007/s10735-006-9075-0] [Cited by in Crossref: 46] [Cited by in F6Publishing: 48] [Article Influence: 3.3] [Reference Citation Analysis]
15 Chen CC, Pekow J, Llado V, Kanneganti M, Lau CW, Mizoguchi A, Mino-Kenudson M, Bissonnette M, Mizoguchi E. Chitinase 3-like-1 expression in colonic epithelial cells as a potentially novel marker for colitis-associated neoplasia. Am J Pathol. 2011;179:1494-1503. [PMID: 21763261 DOI: 10.1016/j.ajpath.2011.05.038] [Cited by in Crossref: 42] [Cited by in F6Publishing: 46] [Article Influence: 4.2] [Reference Citation Analysis]
16 Johansen JS, Krabbe KS, Møller K, Pedersen BK. Circulating YKL-40 levels during human endotoxaemia. Clin Exp Immunol. 2005;140:343-348. [PMID: 15807860 DOI: 10.1111/j.1365-2249.2005.02763.x] [Cited by in Crossref: 39] [Cited by in F6Publishing: 39] [Article Influence: 2.4] [Reference Citation Analysis]
17 Goldring MB. Cartilage and Chondrocytes. Kelley's Textbook of Rheumatology. Elsevier; 2013. pp. 33-60.e10. [DOI: 10.1016/b978-1-4377-1738-9.00003-7] [Cited by in Crossref: 6] [Article Influence: 0.8] [Reference Citation Analysis]
18 Jacques C, Recklies AD, Levy A, Berenbaum F. HC-gp39 contributes to chondrocyte differentiation by inducing SOX9 and type II collagen expressions. Osteoarthritis Cartilage 2007;15:138-46. [PMID: 16949314 DOI: 10.1016/j.joca.2006.07.003] [Cited by in Crossref: 30] [Cited by in F6Publishing: 26] [Article Influence: 2.0] [Reference Citation Analysis]
19 Canpolat U, Aytemir K, Hazirolan T, Özer N, Oto A. Serum YKL-40 as a Marker of Left Atrial Fibrosis Assessed by Delayed Enhancement MRI in Lone Atrial Fibrillation: YKL-40 AND ATRIAL FIBROSIS. Pacing and Clinical Electrophysiology 2015;38:1386-95. [DOI: 10.1111/pace.12729] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
20 Schultz NA, Christensen IJ, Werner J, Giese N, Jensen BV, Larsen O, Bjerregaard JK, Pfeiffer P, Calatayud D, Nielsen SE. Diagnostic and Prognostic Impact of Circulating YKL-40, IL-6, and CA 19.9 in Patients with Pancreatic Cancer. PLoS One. 2013;8:e67059. [PMID: 23840582 DOI: 10.1371/journal.pone.0067059] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 2.8] [Reference Citation Analysis]
21 Lin YS, Liu YF, Chou YE, Yang SF, Chien MH, Wu CH, Chou CH, Cheng CW, Wang PH. Correlation of chitinase 3-like 1 single nucleotide polymorphisms and haplotypes with uterine cervical cancer in Taiwanese women. PLoS One 2014;9:e104038. [PMID: 25203433 DOI: 10.1371/journal.pone.0104038] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.3] [Reference Citation Analysis]
22 Mathiasen AB, Henningsen KMA, Harutyunyan MJ, Mygind ND, Kastrup J. YKL-40: a new biomarker in cardiovascular disease? Biomarkers in Medicine 2010;4:591-600. [DOI: 10.2217/bmm.10.58] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 1.8] [Reference Citation Analysis]
23 Kido J, Bando Y, Bando M, Kajiura Y, Hiroshima Y, Inagaki Y, Murata H, Ikuta T, Kido R, Naruishi K, Funaki M, Nagata T. YKL-40 level in gingival crevicular fluid from patients with periodontitis and type 2 diabetes. Oral Dis. 2015;21:667-673. [PMID: 25740558 DOI: 10.1111/odi.12334] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 1.2] [Reference Citation Analysis]
24 Lai T, Wu D, Chen M, Cao C, Jing Z, Huang L, Lv Y, Zhao X, Lv Q, Wang Y, Li D, Wu B, Shen H. YKL-40 expression in chronic obstructive pulmonary disease: relation to acute exacerbations and airway remodeling. Respir Res 2016;17:31. [PMID: 27013031 DOI: 10.1186/s12931-016-0338-3] [Cited by in Crossref: 15] [Cited by in F6Publishing: 23] [Article Influence: 3.0] [Reference Citation Analysis]
25 Scully S, Yan W, Bentley B, Cao QJ, Shao R. Inhibitory activity of YKL-40 in mammary epithelial cell differentiation and polarization induced by lactogenic hormones: a role in mammary tissue involution. PLoS One 2011;6:e25819. [PMID: 21991364 DOI: 10.1371/journal.pone.0025819] [Cited by in Crossref: 22] [Cited by in F6Publishing: 24] [Article Influence: 2.2] [Reference Citation Analysis]
26 Yamac D, Ozturk B, Coskun U, Tekin E, Sancak B, Yildiz R, Atalay C. Serum YKL-40 levels as a prognostic factor in patients with locally advanced breast cancer. Adv Ther 2008;25:801-9. [PMID: 18670741 DOI: 10.1007/s12325-008-0082-2] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 1.9] [Reference Citation Analysis]
27 Goldring MB. Cartilage and Chondrocytes. Kelley's Textbook of Rheumatology. Elsevier; 2009. pp. 37-69. [DOI: 10.1016/b978-1-4160-3285-4.10003-8] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
28 Gronlund B, Høgdall E, Christensen I, Johansen J, Nørgaard-pedersen B, Engelholm S, Høgdall C. Pre-Treatment Prediction of Chemoresistance in Second-Line Chemotherapy of Ovarian Carcinoma: Value of Serological Tumor Marker Determination (Tetranectin, YKL-40, CASA, CA 125). Int J Biol Markers 2006;21:141-8. [DOI: 10.1177/172460080602100302] [Cited by in Crossref: 15] [Cited by in F6Publishing: 9] [Article Influence: 5.0] [Reference Citation Analysis]
29 Komi DE, Kazemi T, Bussink AP. New Insights Into the Relationship Between Chitinase-3-Like-1 and Asthma. Curr Allergy Asthma Rep 2016;16:57. [PMID: 27438466 DOI: 10.1007/s11882-016-0637-2] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 4.0] [Reference Citation Analysis]
30 Zhao T, Su Z, Li Y, Zhang X, You Q. Chitinase-3 Like-protein-1 function and its role in diseases. Signal Transduct Target Ther. 2020;5:201. [PMID: 32929074 DOI: 10.1038/s41392-020-00303-7] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 14.0] [Reference Citation Analysis]
31 Ku BM, Lee YK, Ryu J, Jeong JY, Choi J, Eun KM, Shin HY, Kim DG, Hwang EM, Yoo JC, Park JY, Roh GS, Kim HJ, Cho GJ, Choi WS, Paek SH, Kang SS. CHI3L1 (YKL-40) is expressed in human gliomas and regulates the invasion, growth and survival of glioma cells. Int J Cancer 2011;128:1316-26. [PMID: 20506295 DOI: 10.1002/ijc.25466] [Cited by in Crossref: 72] [Cited by in F6Publishing: 75] [Article Influence: 7.2] [Reference Citation Analysis]
32 Peng H, Su Q, Lin ZC, Zhu XH, Peng MS, Lv ZB. Potential suppressive effects of theophylline on human rectal cancer SW480 cells in vitro by inhibiting YKL-40 expression. Oncol Lett 2018;15:7403-8. [PMID: 29731892 DOI: 10.3892/ol.2018.8220] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
33 Pelloski CE, Ballman KV, Furth AF, Zhang L, Lin E, Sulman EP, Bhat K, McDonald JM, Yung WK, Colman H, Woo SY, Heimberger AB, Suki D, Prados MD, Chang SM, Barker FG 2nd, Buckner JC, James CD, Aldape K. Epidermal growth factor receptor variant III status defines clinically distinct subtypes of glioblastoma. J Clin Oncol 2007;25:2288-94. [PMID: 17538175 DOI: 10.1200/JCO.2006.08.0705] [Cited by in Crossref: 199] [Cited by in F6Publishing: 111] [Article Influence: 14.2] [Reference Citation Analysis]
34 Martel-Pelletier J, Boileau C, Pelletier JP, Roughley PJ. Cartilage in normal and osteoarthritis conditions. Best Pract Res Clin Rheumatol. 2008;22:351-384. [PMID: 18455690 DOI: 10.1016/j.berh.2008.02.001] [Cited by in Crossref: 298] [Cited by in F6Publishing: 264] [Article Influence: 22.9] [Reference Citation Analysis]
35 Wang Y, Ripa RS, Johansen JS, Gabrielsen A, Steinbruchel DA, Friis T, Bindslev L, Haack-Sørensen M, Jørgensen E, Kastrup J. YKL-40 a new biomarker in patients with acute coronary syndrome or stable coronary artery disease. Scand Cardiovasc J. 2008;42:295-302. [PMID: 18615353 DOI: 10.1080/14017430802220567] [Cited by in Crossref: 73] [Cited by in F6Publishing: 71] [Article Influence: 6.1] [Reference Citation Analysis]
36 Fukushima N, Koopmann J, Sato N, Prasad N, Carvalho R, Leach SD, Hruban RH, Goggins M. Gene expression alterations in the non-neoplastic parenchyma adjacent to infiltrating pancreatic ductal adenocarcinoma. Mod Pathol. 2005;18:779-787. [PMID: 15791284 DOI: 10.1038/modpathol.3800337] [Cited by in Crossref: 57] [Cited by in F6Publishing: 48] [Article Influence: 3.6] [Reference Citation Analysis]
37 Jefri M, Huang YN, Huang WC, Tai CS, Chen WL. YKL-40 regulated epithelial-mesenchymal transition and migration/invasion enhancement in non-small cell lung cancer. BMC Cancer 2015;15:590. [PMID: 26275425 DOI: 10.1186/s12885-015-1592-3] [Cited by in Crossref: 36] [Cited by in F6Publishing: 28] [Article Influence: 6.0] [Reference Citation Analysis]
38 Bottegoni C, Muzzarelli RA, Giovannini F, Busilacchi A, Gigante A. Oral chondroprotection with nutraceuticals made of chondroitin sulphate plus glucosamine sulphate in osteoarthritis. Carbohydrate Polymers 2014;109:126-38. [DOI: 10.1016/j.carbpol.2014.03.033] [Cited by in Crossref: 40] [Cited by in F6Publishing: 34] [Article Influence: 5.7] [Reference Citation Analysis]
39 Liton PB, Liu X, Stamer WD, Challa P, Epstein DL, Gonzalez P. Specific targeting of gene expression to a subset of human trabecular meshwork cells using the chitinase 3-like 1 promoter. Invest Ophthalmol Vis Sci 2005;46:183-90. [PMID: 15623772 DOI: 10.1167/iovs.04-0330] [Cited by in Crossref: 36] [Cited by in F6Publishing: 35] [Article Influence: 2.3] [Reference Citation Analysis]
40 Faibish M, Francescone R, Bentley B, Yan W, Shao R. A YKL-40-neutralizing antibody blocks tumor angiogenesis and progression: a potential therapeutic agent in cancers. Mol Cancer Ther 2011;10:742-51. [PMID: 21357475 DOI: 10.1158/1535-7163.MCT-10-0868] [Cited by in Crossref: 99] [Cited by in F6Publishing: 73] [Article Influence: 9.9] [Reference Citation Analysis]
41 Eldaly MN, Metwally FM, Shousha WG, El-Saiid AS, Ramadan SS. Clinical Potentials of miR-576-3p, miR-613, NDRG2 and YKL40 in Colorectal Cancer Patients. Asian Pac J Cancer Prev 2020;21:1689-95. [PMID: 32592365 DOI: 10.31557/APJCP.2020.21.6.1689] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
42 Aigner T, Dudhia J. Genomics of osteoarthritis: . Current Opinion in Rheumatology 2003;15:634-40. [DOI: 10.1097/00002281-200309000-00019] [Cited by in Crossref: 36] [Cited by in F6Publishing: 34] [Article Influence: 2.0] [Reference Citation Analysis]
43 Ho YY, Baron M, Recklies AD, Roughley PJ, Mort JS. Cells from the skin of patients with systemic sclerosis secrete chitinase 3-like protein 1. BBA Clin 2014;1:2-11. [PMID: 26675476 DOI: 10.1016/j.bbacli.2013.12.001] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
44 Correale J, Fiol M. Chitinase effects on immune cell response in neuromyelitis optica and multiple sclerosis. Mult Scler 2011;17:521-31. [PMID: 21159721 DOI: 10.1177/1352458510392619] [Cited by in Crossref: 54] [Cited by in F6Publishing: 51] [Article Influence: 4.9] [Reference Citation Analysis]
45 Kang MJ, Kim JE, Park JW, Choi HJ, Bae SJ, Choi SI, Hong JT, Hwang DY. Effects of Gallotannin-Enriched Extract of Galla Rhois on the Activation of Apoptosis, Cell Cycle Arrest, and Inhibition of Migration Ability in LLC1 Cells and LLC1 Tumors. Pathol Oncol Res 2021;27:588084. [PMID: 34257536 DOI: 10.3389/pore.2021.588084] [Reference Citation Analysis]
46 Thomsen SB, Rathcke CN, Skaaby T, Linneberg A, Vestergaard H. The Association between genetic variations of CHI3L1, levels of the encoded glycoprotein YKL-40 and the lipid profile in a Danish population. PLoS One 2012;7:e47094. [PMID: 23071724 DOI: 10.1371/journal.pone.0047094] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 1.4] [Reference Citation Analysis]
47 Gianazza E, Wait R, Begum S, Eberini I, Campagnoli M, Labò S, Galliano M. Mapping the 5–50-kDa fraction of human amniotic fluid proteins by 2-DE and ESI-MS. Prot Clin Appl 2007;1:167-75. [DOI: 10.1002/prca.200600543] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 1.1] [Reference Citation Analysis]
48 Patil CG, Nuño M, Elramsisy A, Mukherjee D, Carico C, Dantis J, Hu J, Yu JS, Fan X, Black KL, Bannykh SI. High levels of phosphorylated MAP kinase are associated with poor survival among patients with glioblastoma during the temozolomide era. Neuro Oncol 2013;15:104-11. [PMID: 23115159 DOI: 10.1093/neuonc/nos272] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 1.8] [Reference Citation Analysis]
49 Seibold MA, Donnelly S, Solon M, Innes A, Woodruff PG, Boot RG, Burchard EG, Fahy JV. Chitotriosidase is the primary active chitinase in the human lung and is modulated by genotype and smoking habit. J Allergy Clin Immunol 2008;122:944-950.e3. [PMID: 18845328 DOI: 10.1016/j.jaci.2008.08.023] [Cited by in Crossref: 69] [Cited by in F6Publishing: 71] [Article Influence: 5.3] [Reference Citation Analysis]
50 Haglund L, Bernier SM, Önnerfjord P, Recklies AD. Proteomic analysis of the LPS-induced stress response in rat chondrocytes reveals induction of innate immune response components in articular cartilage. Matrix Biology 2008;27:107-18. [DOI: 10.1016/j.matbio.2007.09.009] [Cited by in Crossref: 47] [Cited by in F6Publishing: 46] [Article Influence: 3.6] [Reference Citation Analysis]
51 Andreassen M, Vestergaard H, Kristensen LØ. Concentrations of the acute phase reactants high-sensitive C-reactive protein and YKL-40 and of interleukin-6 before and after treatment in patients with acromegaly and growth hormone deficiency. Clinical Endocrinology 2007;67:909-16. [DOI: 10.1111/j.1365-2265.2007.02986.x] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 1.1] [Reference Citation Analysis]
52 Chung C, Tallerico T, Seeman P. Schizophrenia hippocampus has elevated expression of chondrex glycoprotein gene. Synapse 2003;50:29-34. [DOI: 10.1002/syn.10228] [Cited by in Crossref: 45] [Cited by in F6Publishing: 44] [Article Influence: 2.5] [Reference Citation Analysis]
53 Xue Q, Chen L, Yu J, Sun K, Ye L, Zheng J. Downregulation of Interleukin-13 Receptor α2 Inhibits Angiogenic Formation Mediated by Chitinase 3-Like 1 in Late Atherosclerotic Lesions of apoE-/- Mice. Front Physiol 2021;12:690109. [PMID: 34349665 DOI: 10.3389/fphys.2021.690109] [Reference Citation Analysis]
54 Jin X, Fu B, Wu ZJ, Zheng XQ, Hu JH, Jin LF, Tang LL. Serum chitinase-3-like protein 1 is a biomarker of liver fibrosis in patients with chronic hepatitis B in China. Hepatobiliary Pancreat Dis Int 2020;19:384-9. [PMID: 32540209 DOI: 10.1016/j.hbpd.2020.05.009] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
55 Tong X, Wang D, Liu S, Ma Y, Li Z, Tian P, Fan H. The YKL-40 protein is a potential biomarker for COPD: a meta-analysis and systematic review. Int J Chron Obstruct Pulmon Dis 2018;13:409-18. [PMID: 29430175 DOI: 10.2147/COPD.S152655] [Cited by in Crossref: 23] [Cited by in F6Publishing: 13] [Article Influence: 7.7] [Reference Citation Analysis]
56 Fu Y, Zhu F, Liu L, Lu S, Ren Z, Mu C, Li R, Song W, Shi C, Ye Y, Wang C. iTRAQ-based proteomic analysis identifies proteins involved in limb regeneration of swimming crab Portunus trituberculatus. Comp Biochem Physiol Part D Genomics Proteomics 2018;26:10-9. [PMID: 29482113 DOI: 10.1016/j.cbd.2018.02.003] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 1.3] [Reference Citation Analysis]
57 Houston DR, Recklies AD, Krupa JC, van Aalten DM. Structure and Ligand-induced Conformational Change of the 39-kDa Glycoprotein from Human Articular Chondrocytes. Journal of Biological Chemistry 2003;278:30206-12. [DOI: 10.1074/jbc.m303371200] [Cited by in Crossref: 104] [Cited by in F6Publishing: 38] [Article Influence: 5.8] [Reference Citation Analysis]
58 Di Rosa M, Szychlinska MA, Tibullo D, Malaguarnera L, Musumeci G. Expression of CHI3L1 and CHIT1 in osteoarthritic rat cartilage model. A morphological study. Eur J Histochem. 2014;58:2423. [PMID: 25308850 DOI: 10.4081/ejh.2014.2423] [Cited by in Crossref: 36] [Cited by in F6Publishing: 41] [Article Influence: 5.1] [Reference Citation Analysis]
59 Bossé Y, Miqdad A, Fournier D, Pépin A, Pibarot P, Mathieu P. Refining molecular pathways leading to calcific aortic valve stenosis by studying gene expression profile of normal and calcified stenotic human aortic valves. Circ Cardiovasc Genet 2009;2:489-98. [PMID: 20031625 DOI: 10.1161/CIRCGENETICS.108.820795] [Cited by in Crossref: 85] [Cited by in F6Publishing: 53] [Article Influence: 7.1] [Reference Citation Analysis]
60 Kucur M, Isman FK, Balci C, Onal B, Hacibekiroglu M, Ozkan F, Ozkan A. Serum YKL-40 levels and chitotriosidase activity as potential biomarkers in primary prostate cancer and benign prostatic hyperplasia. Urol Oncol. 2008;26:47-52. [PMID: 18190830 DOI: 10.1016/j.urolonc.2007.07.020] [Cited by in Crossref: 28] [Cited by in F6Publishing: 33] [Article Influence: 2.2] [Reference Citation Analysis]
61 Nøjgaard C, Johansen JS, Bjerregaard P, Bojesen SE, Becker U. Plasma YKL-40 in Inuit and Danes. Alcohol Alcohol 2015;50:11-7. [PMID: 25332349 DOI: 10.1093/alcalc/agu072] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
62 Shao R, Cao QJ, Arenas RB, Bigelow C, Bentley B, Yan W. Breast cancer expression of YKL-40 correlates with tumour grade, poor differentiation, and other cancer markers. Br J Cancer. 2011;105:1203-1209. [PMID: 21934681 DOI: 10.1038/bjc.2011.347] [Cited by in Crossref: 37] [Cited by in F6Publishing: 37] [Article Influence: 3.7] [Reference Citation Analysis]
63 Mohanty AK, Fisher AJ, Yu Z, Pradeep MA, Janjanam J, Kaushik JK. Cloning, expression, characterization and crystallization of BRP39, a signalling glycoprotein expressed during mammary gland apoptosis. Protein Expr Purif 2009;64:213-8. [PMID: 19041398 DOI: 10.1016/j.pep.2008.11.001] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 0.8] [Reference Citation Analysis]
64 Ruhl T, Stromps JP, Depenau LM, Kim BS, Pallua N. Concentration of Chondrogenic Soluble Factors in Freshly Harvested Lipoaspirate. Ann Plast Surg 2019;83:344-51. [PMID: 30994491 DOI: 10.1097/SAP.0000000000001936] [Reference Citation Analysis]
65 Bohr S, Patel SJ, Vasko R, Shen K, Golberg A, Berthiaume F, Yarmush ML. The Role of CHI3L1 (Chitinase-3-Like-1) in the Pathogenesis of Infections in Burns in a Mouse Model. PLoS One 2015;10:e0140440. [PMID: 26528713 DOI: 10.1371/journal.pone.0140440] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.5] [Reference Citation Analysis]
66 Jeet V, Tevz G, Lehman M, Hollier B, Nelson C. Elevated YKL40 is associated with advanced prostate cancer (PCa) and positively regulates invasion and migration of PCa cells. Endocr Relat Cancer 2014;21:723-37. [PMID: 24981110 DOI: 10.1530/ERC-14-0267] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 1.9] [Reference Citation Analysis]
67 Recklies AD, Ling H, White C, Bernier SM. Inflammatory Cytokines Induce Production of CHI3L1 by Articular Chondrocytes. Journal of Biological Chemistry 2005;280:41213-21. [DOI: 10.1074/jbc.m510146200] [Cited by in Crossref: 118] [Cited by in F6Publishing: 57] [Article Influence: 7.4] [Reference Citation Analysis]
68 Itik V, Kemik O, Kemik A, Dulger AC, Sümer A, Soyoral YU, Begenik H, Purisa S, Kotan C. Serum YKL-40 Levels in Patients with Gastric Cancer. Biomark Cancer 2011;3:25-30. [PMID: 24179388 DOI: 10.4137/BIC.S7154] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
69 Johansen JS, Pedersen AN, Schroll M, Jørgensen T, Pedersen BK, Bruunsgaard H. High serum YKL-40 level in a cohort of octogenarians is associated with increased risk of all-cause mortality. Clin Exp Immunol 2008;151:260-6. [PMID: 18070151 DOI: 10.1111/j.1365-2249.2007.03561.x] [Cited by in Crossref: 32] [Cited by in F6Publishing: 37] [Article Influence: 2.3] [Reference Citation Analysis]
70 Areshkov PO, Avdieiev SS, Balynska OV, Leroith D, Kavsan VM. Two closely related human members of chitinase-like family, CHI3L1 and CHI3L2, activate ERK1/2 in 293 and U373 cells but have the different influence on cell proliferation. Int J Biol Sci 2012;8:39-48. [PMID: 22211103 DOI: 10.7150/ijbs.8.39] [Cited by in Crossref: 42] [Cited by in F6Publishing: 38] [Article Influence: 4.2] [Reference Citation Analysis]
71 Chen CC, Llado V, Eurich K, Tran HT, Mizoguchi E. Carbohydrate-binding motif in chitinase 3-like 1 (CHI3L1/YKL-40) specifically activates Akt signaling pathway in colonic epithelial cells. Clin Immunol. 2011;140:268-275. [PMID: 21546314 DOI: 10.1016/j.clim.2011.04.007] [Cited by in Crossref: 57] [Cited by in F6Publishing: 62] [Article Influence: 5.7] [Reference Citation Analysis]
72 Nielsen KR, Steffensen R, Boegsted M, Baech J, Lundbye-Christensen S, Hetland ML, Krintel SB, Johnsen HE, Nyegaard M, Johansen JS. Promoter polymorphisms in the chitinase 3-like 1 gene influence the serum concentration of YKL-40 in Danish patients with rheumatoid arthritis and in healthy subjects. Arthritis Res Ther 2011;13:R109. [PMID: 21714862 DOI: 10.1186/ar3391] [Cited by in Crossref: 27] [Cited by in F6Publishing: 30] [Article Influence: 2.7] [Reference Citation Analysis]
73 Zheng T, Rabach M, Chen NY, Rabach L, Hu X, Elias JA, Zhu Z. Molecular cloning and functional characterization of mouse chitotriosidase. Gene. 2005;357:37-46. [PMID: 16005164 DOI: 10.1016/j.gene.2005.05.006] [Cited by in Crossref: 32] [Cited by in F6Publishing: 32] [Article Influence: 2.0] [Reference Citation Analysis]
74 Muszyński P, Groblewska M, Kulczyńska-Przybik A, Kułakowska A, Mroczko B. YKL-40 as a Potential Biomarker and a Possible Target in Therapeutic Strategies of Alzheimer's Disease. Curr Neuropharmacol 2017;15:906-17. [PMID: 28183245 DOI: 10.2174/1570159X15666170208124324] [Cited by in Crossref: 24] [Cited by in F6Publishing: 20] [Article Influence: 8.0] [Reference Citation Analysis]
75 Stoffel K, Engler H, Kuster M, Riesen W. Changes in Biochemical Markers after Lower Limb Fractures. Clinical Chemistry 2007;53:131-4. [DOI: 10.1373/clinchem.2006.076976] [Cited by in Crossref: 59] [Cited by in F6Publishing: 51] [Article Influence: 4.2] [Reference Citation Analysis]
76 Di Rosa M, Brundo VM, Malaguarnera L. New insights on chitinases immunologic activities. World J Immunol 2016; 6(2): 96-104 [DOI: 10.5411/wji.v6.i2.96] [Cited by in CrossRef: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
77 Lee CG, Hartl D, Lee GR, Koller B, Matsuura H, Da Silva CA, Sohn MH, Cohn L, Homer RJ, Kozhich AA. Role of breast regression protein 39 (BRP-39)/chitinase 3-like-1 in Th2 and IL-13-induced tissue responses and apoptosis. J Exp Med. 2009;206:1149-1166. [PMID: 19414556 DOI: 10.1084/jem.20081271] [Cited by in Crossref: 275] [Cited by in F6Publishing: 278] [Article Influence: 22.9] [Reference Citation Analysis]
78 Cheng SP, Lee JJ, Chang YC, Lin CH, Li YS, Liu CL. Overexpression of chitinase-3-like protein 1 is associated with structural recurrence in patients with differentiated thyroid cancer. J Pathol 2020;252:114-24. [PMID: 32613636 DOI: 10.1002/path.5503] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
79 Bernardi D, Podswiadek M, Zaninotto M, Punzi L, Plebani M. YKL-40 as a marker of joint involvement in inflammatory bowel disease. Clin Chem. 2003;49:1685-1688. [PMID: 14500601 DOI: 10.1373/49.10.1685] [Cited by in Crossref: 20] [Cited by in F6Publishing: 22] [Article Influence: 1.1] [Reference Citation Analysis]
80 Allin KH, Bojesen SE, Johansen JS, Nordestgaard BG. Cancer risk by combined levels of YKL-40 and C-reactive protein in the general population. Br J Cancer 2012;106:199-205. [PMID: 22095223 DOI: 10.1038/bjc.2011.501] [Cited by in Crossref: 23] [Cited by in F6Publishing: 20] [Article Influence: 2.3] [Reference Citation Analysis]
81 Masui K, Cloughesy TF, Mischel PS. Review: molecular pathology in adult high-grade gliomas: from molecular diagnostics to target therapies. Neuropathol Appl Neurobiol 2012;38:271-91. [PMID: 22098029 DOI: 10.1111/j.1365-2990.2011.01238.x] [Cited by in Crossref: 77] [Cited by in F6Publishing: 71] [Article Influence: 8.6] [Reference Citation Analysis]
82 Lee CG, Da Silva CA, Dela Cruz CS, Ahangari F, Ma B, Kang MJ, He CH, Takyar S, Elias JA. Role of chitin and chitinase/chitinase-like proteins in inflammation, tissue remodeling, and injury. Annu Rev Physiol. 2011;73:479-501. [PMID: 21054166 DOI: 10.1146/annurev-physiol-012110-142250] [Cited by in Crossref: 471] [Cited by in F6Publishing: 469] [Article Influence: 47.1] [Reference Citation Analysis]
83 Roslind A, Johansen JS, Junker N, Nielsen DL, Dzaferi H, Price PA, Balslev E. YKL-40 expression in benign and malignant lesions of the breast: a methodologic study. Appl Immunohistochem Mol Morphol 2007;15:371-81. [PMID: 18091378 DOI: 10.1097/01.pai.0000213146.77772.6a] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 1.1] [Reference Citation Analysis]
84 Schmidt H, Johansen JS, Gehl J, Geertsen PF, Fode K, von der Maase H. Elevated serum level of YKL-40 is an independent prognostic factor for poor survival in patients with metastatic melanoma. Cancer. 2006;106:1130-1139. [PMID: 16456816 DOI: 10.1002/cncr.21678] [Cited by in Crossref: 86] [Cited by in F6Publishing: 79] [Article Influence: 5.7] [Reference Citation Analysis]
85 Djordjevic MA, Bezos A, Susanti, Marmuse L, Driguez H, Samain E, Vauzeilles B, Beau JM, Kordbacheh F, Rolfe BG, Schwörer R, Daines AM, Gresshoff PM, Parish CR. Lipo-chitin oligosaccharides, plant symbiosis signalling molecules that modulate mammalian angiogenesis in vitro. PLoS One 2014;9:e112635. [PMID: 25536397 DOI: 10.1371/journal.pone.0112635] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 1.7] [Reference Citation Analysis]
86 Rathcke CN, Holmkvist J, Husmoen LL, Hansen T, Pedersen O, Vestergaard H, Linneberg A. Association of polymorphisms of the CHI3L1 gene with asthma and atopy: a populations-based study of 6514 Danish adults. PLoS One 2009;4:e6106. [PMID: 19568425 DOI: 10.1371/journal.pone.0006106] [Cited by in Crossref: 35] [Cited by in F6Publishing: 37] [Article Influence: 2.9] [Reference Citation Analysis]
87 Long X, Hu H, Li S, Chen M, Cai J, Song B. Hippocampal YKL-40 expression in rats after status epilepticus. Epilepsy Research 2016;125:52-7. [DOI: 10.1016/j.eplepsyres.2016.05.014] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
88 Di Rosa M, Distefano G, Zorena K, Malaguarnera L. Chitinases and immunity: Ancestral molecules with new functions. Immunobiology 2016;221:399-411. [PMID: 26686909 DOI: 10.1016/j.imbio.2015.11.014] [Cited by in Crossref: 51] [Cited by in F6Publishing: 47] [Article Influence: 8.5] [Reference Citation Analysis]
89 Weiss L, Bernstein S, Jones R, Amunugama R, Krizman D, Jebailey L, Almogi-Hazan O, Yekhtin Z, Shiner R, Reibstein I, Triche E, Slavin S, Or R, Barnea ER. Preimplantation factor (PIF) analog prevents type I diabetes mellitus (TIDM) development by preserving pancreatic function in NOD mice. Endocrine 2011;40:41-54. [PMID: 21424847 DOI: 10.1007/s12020-011-9438-5] [Cited by in Crossref: 35] [Cited by in F6Publishing: 37] [Article Influence: 3.5] [Reference Citation Analysis]
90 Lee CG, Elias JA. Role of breast regression protein-39/YKL-40 in asthma and allergic responses. Allergy Asthma Immunol Res 2010;2:20-7. [PMID: 20224674 DOI: 10.4168/aair.2010.2.1.20] [Cited by in Crossref: 51] [Cited by in F6Publishing: 51] [Article Influence: 4.3] [Reference Citation Analysis]
91 Chen XH, Xie ZH, Sun SJ, Cai G. Cloning of a rat lung fibrogenic factor. Gene 2006;384:9-17. [DOI: 10.1016/j.gene.2006.06.026] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
92 Johansen JS, Bojesen SE, Mylin AK, Frikke-schmidt R, Price PA, Nordestgaard BG. Elevated Plasma YKL-40 Predicts Increased Risk of Gastrointestinal Cancer and Decreased Survival After Any Cancer Diagnosis in the General Population. JCO 2009;27:572-8. [DOI: 10.1200/jco.2008.18.8367] [Cited by in Crossref: 63] [Cited by in F6Publishing: 24] [Article Influence: 5.3] [Reference Citation Analysis]
93 Koch BE, Stougaard J, Spaink HP. Keeping track of the growing number of biological functions of chitin and its interaction partners in biomedical research. Glycobiology 2015;25:469-82. [PMID: 25595947 DOI: 10.1093/glycob/cwv005] [Cited by in Crossref: 40] [Cited by in F6Publishing: 34] [Article Influence: 6.7] [Reference Citation Analysis]
94 Richter B, Roslind A, Hesse U, Nordling J, Johansen JS, Horn T, Hansen AB. YKL-40 and mast cells are associated with detrusor fibrosis in patients diagnosed with bladder pain syndrome/interstitial cystitis according to the 2008 criteria of the European Society for the Study of Interstitial Cystitis. Histopathology 2010;57:371-83. [PMID: 20840668 DOI: 10.1111/j.1365-2559.2010.03640.x] [Cited by in Crossref: 32] [Cited by in F6Publishing: 27] [Article Influence: 3.2] [Reference Citation Analysis]
95 Craig-Schapiro R, Perrin RJ, Roe CM, Xiong C, Carter D, Cairns NJ, Mintun MA, Peskind ER, Li G, Galasko DR, Clark CM, Quinn JF, D'Angelo G, Malone JP, Townsend RR, Morris JC, Fagan AM, Holtzman DM. YKL-40: a novel prognostic fluid biomarker for preclinical Alzheimer's disease. Biol Psychiatry 2010;68:903-12. [PMID: 21035623 DOI: 10.1016/j.biopsych.2010.08.025] [Cited by in Crossref: 240] [Cited by in F6Publishing: 241] [Article Influence: 24.0] [Reference Citation Analysis]
96 Steinke J, Samietz S, Friedrich N, Weiss S, Michalik S, Biffar R, Nauck M, Völker U, Wallaschofski H, Pietzner M, Hannemann A. Associations of plasma YKL-40 concentrations with heel ultrasound parameters and bone turnover markers in the general adult population. Bone 2020;141:115675. [PMID: 33031973 DOI: 10.1016/j.bone.2020.115675] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
97 Badariotti F, Kypriotou M, Lelong C, Dubos MP, Renard E, Galera P, Favrel P. The phylogenetically conserved molluscan chitinase-like protein 1 (Cg-Clp1), homologue of human HC-gp39, stimulates proliferation and regulates synthesis of extracellular matrix components of mammalian chondrocytes. J Biol Chem 2006;281:29583-96. [PMID: 16882657 DOI: 10.1074/jbc.M605687200] [Cited by in Crossref: 47] [Cited by in F6Publishing: 19] [Article Influence: 3.1] [Reference Citation Analysis]
98 Pan JJ, Ge YS, Xu GL, Jia WD, Liu WF, Li JS, Liu WB. The expression of chitinase 3-like 1: a novel prognostic predictor for hepatocellular carcinoma. J Cancer Res Clin Oncol. 2013;139:1043-1054. [PMID: 23525579 DOI: 10.1007/s00432-013-1415-3] [Cited by in Crossref: 9] [Cited by in F6Publishing: 13] [Article Influence: 1.1] [Reference Citation Analysis]
99 Erturk K, Tas F, Serilmez M, Bilgin E, Yasasever V. Clinical Signifıcance of Serum Ykl-40 (Chitinase-3-Like-1 Protein) as a Biomarker in Melanoma: an Analysis of 112 Turkish Patients. Asian Pac J Cancer Prev 2017;18:1383-7. [PMID: 28612591 DOI: 10.22034/APJCP.2017.18.5.1383] [Cited by in F6Publishing: 6] [Reference Citation Analysis]
100 Tang Y, Le W. Differential Roles of M1 and M2 Microglia in Neurodegenerative Diseases. Mol Neurobiol. 2016;53:1181-1194. [PMID: 25598354 DOI: 10.1007/s12035-014-9070-5] [Cited by in Crossref: 712] [Cited by in F6Publishing: 710] [Article Influence: 118.7] [Reference Citation Analysis]
101 Kastrup J. Can YKL-40 be a new inflammatory biomarker in cardiovascular disease? Immunobiology 2012;217:483-91. [DOI: 10.1016/j.imbio.2011.04.007] [Cited by in Crossref: 55] [Cited by in F6Publishing: 50] [Article Influence: 6.1] [Reference Citation Analysis]
102 Bussink AP, Speijer D, Aerts JM, Boot RG. Evolution of mammalian chitinase(-like) members of family 18 glycosyl hydrolases. Genetics. 2007;177:959-970. [PMID: 17720922 DOI: 10.1534/genetics.107.075846] [Cited by in Crossref: 182] [Cited by in F6Publishing: 182] [Article Influence: 13.0] [Reference Citation Analysis]
103 Johansen JS, Høyer PE, Larsen LA, Price PA, Møllgård K. YKL-40 protein expression in the early developing human musculoskeletal system. J Histochem Cytochem 2007;55:1213-28. [PMID: 17712177 DOI: 10.1369/jhc.7A7245.2007] [Cited by in Crossref: 67] [Cited by in F6Publishing: 29] [Article Influence: 4.8] [Reference Citation Analysis]
104 Furuhashi K, Suda T, Nakamura Y, Inui N, Hashimoto D, Miwa S, Hayakawa H, Kusagaya H, Nakano Y, Nakamura H, Chida K. Increased expression of YKL-40, a chitinase-like protein, in serum and lung of patients with idiopathic pulmonary fibrosis. Respir Med 2010;104:1204-10. [PMID: 20347285 DOI: 10.1016/j.rmed.2010.02.026] [Cited by in Crossref: 80] [Cited by in F6Publishing: 77] [Article Influence: 7.3] [Reference Citation Analysis]
105 Erzin Y, Uzun H, Karatas A, Celik AF. Serum YKL-40 as a marker of disease activity and stricture formation in patients with Crohn’s disease. J Gastroenterol Hepatol. 2008;23:e357-e362. [PMID: 17725598 DOI: 10.1111/j.1440-1746.2007.05121.x] [Cited by in Crossref: 37] [Cited by in F6Publishing: 35] [Article Influence: 2.6] [Reference Citation Analysis]
106 Korthagen NM, van Moorsel CH, Barlo NP, Ruven HJ, Kruit A, Heron M, van den Bosch JM, Grutters JC. Serum and BALF YKL-40 levels are predictors of survival in idiopathic pulmonary fibrosis. Respir Med 2011;105:106-13. [PMID: 20888745 DOI: 10.1016/j.rmed.2010.09.012] [Cited by in Crossref: 78] [Cited by in F6Publishing: 69] [Article Influence: 7.8] [Reference Citation Analysis]
107 Johansen JS, Jensen BV, Roslind A, Price PA. Is YKL-40 a new therapeutic target in cancer? Expert Opinion on Therapeutic Targets 2007;11:219-34. [DOI: 10.1517/14728222.11.2.219] [Cited by in Crossref: 38] [Cited by in F6Publishing: 39] [Article Influence: 2.7] [Reference Citation Analysis]
108 Catalán V, Gómez-Ambrosi J, Rodríguez A, Ramírez B, Izaguirre M, Hernández-Lizoain JL, Baixauli J, Martí P, Valentí V, Moncada R, Silva C, Salvador J, Frühbeck G. Increased Obesity-Associated Circulating Levels of the Extracellular Matrix Proteins Osteopontin, Chitinase-3 Like-1 and Tenascin C Are Associated with Colon Cancer. PLoS One 2016;11:e0162189. [PMID: 27612200 DOI: 10.1371/journal.pone.0162189] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 3.0] [Reference Citation Analysis]
109 Sutherland TE, Maizels RM, Allen JE. Chitinases and chitinase-like proteins: potential therapeutic targets for the treatment of T-helper type 2 allergies. Clin Exp Allergy. 2009;39:943-955. [PMID: 19400900 DOI: 10.1111/j.1365-2222.2009.03243.x] [Cited by in Crossref: 61] [Cited by in F6Publishing: 62] [Article Influence: 5.1] [Reference Citation Analysis]
110 Michelsen AE, Rathcke CN, Skjelland M, Holm S, Ranheim T, Krohg-Sørensen K, Klingvall MF, Brosstad F, Oie E, Vestergaard H, Aukrust P, Halvorsen B. Increased YKL-40 expression in patients with carotid atherosclerosis. Atherosclerosis 2010;211:589-95. [PMID: 20347092 DOI: 10.1016/j.atherosclerosis.2010.02.035] [Cited by in Crossref: 50] [Cited by in F6Publishing: 51] [Article Influence: 4.5] [Reference Citation Analysis]
111 Kamba A, Lee IA, Mizoguchi E. Potential association between TLR4 and chitinase 3-like 1 (CHI3L1/YKL-40) signaling on colonic epithelial cells in inflammatory bowel disease and colitis-associated cancer. Curr Mol Med 2013;13:1110-21. [PMID: 23170831 DOI: 10.2174/1566524011313070006] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 3.0] [Reference Citation Analysis]
112 Hoover DJ, Zhu V, Chen R, Briley K, Rameshwar P, Cohen S, Coffman FD. Expression of the chitinase family glycoprotein YKL-40 in undifferentiated, differentiated and trans-differentiated mesenchymal stem cells. PLoS One. 2013;8:e62491. [PMID: 23671604 DOI: 10.1371/journal.pone.0062491] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.3] [Reference Citation Analysis]
113 Funkhouser JD, Aronson NN Jr. Chitinase family GH18: evolutionary insights from the genomic history of a diverse protein family. BMC Evol Biol 2007;7:96. [PMID: 17594485 DOI: 10.1186/1471-2148-7-96] [Cited by in Crossref: 184] [Cited by in F6Publishing: 169] [Article Influence: 13.1] [Reference Citation Analysis]
114 Fontana RJ, Dienstag JL, Bonkovsky HL, Sterling RK, Naishadham D, Goodman ZD, Lok AS, Wright EC, Su GL; HALT-C Trial Group. Serum fibrosis markers are associated with liver disease progression in non-responder patients with chronic hepatitis C. Gut 2010;59:1401-9. [PMID: 20675691 DOI: 10.1136/gut.2010.207423] [Cited by in Crossref: 70] [Cited by in F6Publishing: 67] [Article Influence: 6.4] [Reference Citation Analysis]
115 Nordenbaek C, Johansen JS, Halberg P, Wiik A, Garbarsch C, Ullman S, Price PA, Jacobsen S. High serum levels of YKL-40 in patients with systemic sclerosis are associated with pulmonary involvement. Scand J Rheumatol. 2005;34:293-297. [PMID: 16195162 DOI: 10.1080/03009740510018598] [Cited by in Crossref: 57] [Cited by in F6Publishing: 52] [Article Influence: 3.6] [Reference Citation Analysis]
116 Svane IM, Pedersen AE, Johansen JS, Johnsen HE, Nielsen D, Kamby C, Ottesen S, Balslev E, Gaarsdal E, Nikolajsen K, Claesson MH. Vaccination with p53 peptide-pulsed dendritic cells is associated with disease stabilization in patients with p53 expressing advanced breast cancer; monitoring of serum YKL-40 and IL-6 as response biomarkers. Cancer Immunol Immunother 2007;56:1485-99. [PMID: 17285289 DOI: 10.1007/s00262-007-0293-4] [Cited by in Crossref: 67] [Cited by in F6Publishing: 58] [Article Influence: 4.8] [Reference Citation Analysis]
117 O'Rourke JL. Gene expression profiling in Helicobacter-induced MALT lymphoma with reference to antigen drive and protective immunization. J Gastroenterol Hepatol 2008;23 Suppl 2:S151-6. [PMID: 19120889 DOI: 10.1111/j.1440-1746.2008.05553.x] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 1.2] [Reference Citation Analysis]
118 Wang S, Hu M, Qian Y, Jiang Z, Shen L, Fu L, Hu Y. CHI3L1 in the pathophysiology and diagnosis of liver diseases. Biomed Pharmacother 2020;131:110680. [PMID: 32861071 DOI: 10.1016/j.biopha.2020.110680] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
119 Peng C, Peng J, Jiang L, You Q, Zheng J, Ning X. YKL-40 protein levels and clinical outcome of human endometrial cancer. J Int Med Res 2010;38:1448-57. [PMID: 20926018 DOI: 10.1177/147323001003800427] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 1.5] [Reference Citation Analysis]
120 Nøjgaard C, Johansen JS, Christensen E, Skovgaard LT, Price PA, Becker U. Serum levels of YKL-40 and PIIINP as prognostic markers in patients with alcoholic liver disease. J Hepatol. 2003;39:179-186. [PMID: 12873813 DOI: 10.1016/s0168-8278(03)00184-3] [Cited by in Crossref: 107] [Cited by in F6Publishing: 43] [Article Influence: 6.3] [Reference Citation Analysis]
121 Coffman FD. Chitinase 3-Like-1 (CHI3L1): a putative disease marker at the interface of proteomics and glycomics. Crit Rev Clin Lab Sci. 2008;45:531-562. [PMID: 19003601 DOI: 10.1080/10408360802334743] [Cited by in Crossref: 77] [Cited by in F6Publishing: 80] [Article Influence: 6.4] [Reference Citation Analysis]
122 Bi J, Lau SH, Lv ZL, Xie D, Li W, Lai YR, Zhong JM, Wu HQ, Su Q, He YL. Overexpression of YKL-40 is an independent prognostic marker in gastric cancer. Hum Pathol. 2009;40:1790-1797. [PMID: 19765801 DOI: 10.1016/j.humpath.2009.07.005] [Cited by in Crossref: 37] [Cited by in F6Publishing: 34] [Article Influence: 3.1] [Reference Citation Analysis]
123 Pouyafar A, Heydarabad MZ, Mahboob S, Mokhtarzadeh A, Rahbarghazi R. Angiogenic potential of YKL-40 in the dynamics of tumor niche. Biomed Pharmacother 2018;100:478-85. [PMID: 29477911 DOI: 10.1016/j.biopha.2018.02.050] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 4.0] [Reference Citation Analysis]
124 Salvatore V, Teti G, Bolzani S, Focaroli S, Durante S, Mazzotti MC, Falconi M. Simulating tumor microenvironment: changes in protein expression in an in vitro co-culture system. Cancer Cell Int 2014;14:40. [PMID: 24883044 DOI: 10.1186/1475-2867-14-40] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
125 Andreassen M, Raymond I, Hildebrandt P, Kistorp C, Rathcke C, Vestergaard H, Faber J, Kristensen LØ. Associations between plasma insulin-like growth factor-I and the markers of inflammation interleukin 6, C-reactive protein and YKL-40 in an elderly background population. Inflamm Res 2010;59:503-10. [DOI: 10.1007/s00011-009-0154-z] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.8] [Reference Citation Analysis]
126 Shapiro F, Flynn E, Calicchio ML. Molecular differentiation in epiphyseal and physeal cartilage. Prominent role for gremlin in maintaining hypertrophic chondrocytes in epiphyseal cartilage. Biochem Biophys Res Commun 2009;390:570-6. [PMID: 19818739 DOI: 10.1016/j.bbrc.2009.10.006] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
127 Pradeep MA, Jagadeesh J, De AK, Kaushik JK, Malakar D, Kumar S, Dang AK, Das SK, Mohanty AK. Purification, sequence characterization and effect of goat oviduct-specific glycoprotein on in vitro embryo development. Theriogenology 2011;75:1005-15. [PMID: 21196036 DOI: 10.1016/j.theriogenology.2010.11.007] [Cited by in Crossref: 32] [Cited by in F6Publishing: 30] [Article Influence: 2.9] [Reference Citation Analysis]
128 Bonneh-Barkay D, Bissel SJ, Wang G, Fish KN, Nicholl GC, Darko SW, Medina-Flores R, Murphey-Corb M, Rajakumar PA, Nyaundi J, Mellors JW, Bowser R, Wiley CA. YKL-40, a marker of simian immunodeficiency virus encephalitis, modulates the biological activity of basic fibroblast growth factor. Am J Pathol 2008;173:130-43. [PMID: 18556781 DOI: 10.2353/ajpath.2008.080045] [Cited by in Crossref: 92] [Cited by in F6Publishing: 74] [Article Influence: 7.1] [Reference Citation Analysis]
129 Singh S, Choudhary S, Anand V, Jaswal S, Verma AK, Kumar S, Kaushik JK, Mohanty AK. New insights into the catalytic inactivity of mammary gland protein-40, a chitinase-like protein expressed during mammary gland involution. Mol Biol Rep 2019;46:2243-57. [DOI: 10.1007/s11033-019-04679-w] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
130 Marott SC, Benn M, Johansen JS, Jensen GB, Tybjærg-Hansen A, Nordestgaard BG. YKL-40 levels and atrial fibrillation in the general population. Int J Cardiol 2013;167:1354-9. [PMID: 22525348 DOI: 10.1016/j.ijcard.2012.04.006] [Cited by in Crossref: 22] [Cited by in F6Publishing: 18] [Article Influence: 2.4] [Reference Citation Analysis]
131 Schultz NA, Johansen JS. YKL-40-A Protein in the Field of Translational Medicine: A Role as a Biomarker in Cancer Patients? Cancers (Basel) 2010;2:1453-91. [PMID: 24281168 DOI: 10.3390/cancers2031453] [Cited by in Crossref: 39] [Cited by in F6Publishing: 37] [Article Influence: 3.5] [Reference Citation Analysis]
132 Egberts F, Kotthoff EM, Gerdes S, Egberts JH, Weichenthal M, Hauschild A. Comparative study of YKL-40, S-100B and LDH as monitoring tools for Stage IV melanoma. Eur J Cancer 2012;48:695-702. [PMID: 21917447 DOI: 10.1016/j.ejca.2011.08.007] [Cited by in Crossref: 39] [Cited by in F6Publishing: 32] [Article Influence: 3.9] [Reference Citation Analysis]
133 Ohi K, Hashimoto R, Yasuda Y, Yoshida T, Takahashi H, Iike N, Iwase M, Kamino K, Ishii R, Kazui H, Fukumoto M, Takamura H, Yamamori H, Azechi M, Ikezawa K, Tanimukai H, Tagami S, Morihara T, Okochi M, Yamada K, Numata S, Ikeda M, Tanaka T, Kudo T, Ueno S, Yoshikawa T, Ohmori T, Iwata N, Ozaki N, Takeda M. The chitinase 3-like 1 gene and schizophrenia: Evidence from a multi-center case–control study and meta-analysis. Schizophrenia Research 2010;116:126-32. [DOI: 10.1016/j.schres.2009.12.002] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 1.5] [Reference Citation Analysis]
134 Otsuka K, Matsumoto H, Niimi A, Muro S, Ito I, Takeda T, Terada K, Yamaguchi M, Matsuoka H, Jinnai M, Oguma T, Nakaji H, Inoue H, Tajiri T, Iwata T, Chin K, Mishima M. Sputum YKL-40 levels and pathophysiology of asthma and chronic obstructive pulmonary disease. Respiration 2012;83:507-19. [PMID: 21968467 DOI: 10.1159/000330840] [Cited by in Crossref: 25] [Cited by in F6Publishing: 26] [Article Influence: 2.5] [Reference Citation Analysis]
135 Brune V, Tiacci E, Pfeil I, Döring C, Eckerle S, van Noesel CJ, Klapper W, Falini B, von Heydebreck A, Metzler D, Bräuninger A, Hansmann ML, Küppers R. Origin and pathogenesis of nodular lymphocyte-predominant Hodgkin lymphoma as revealed by global gene expression analysis. J Exp Med 2008;205:2251-68. [PMID: 18794340 DOI: 10.1084/jem.20080809] [Cited by in Crossref: 233] [Cited by in F6Publishing: 199] [Article Influence: 17.9] [Reference Citation Analysis]
136 Bhat KP, Pelloski CE, Zhang Y, Kim SH, deLaCruz C, Rehli M, Aldape KD. Selective repression of YKL-40 by NF-kappaB in glioma cell lines involves recruitment of histone deacetylase-1 and -2. FEBS Lett 2008;582:3193-200. [PMID: 18708058 DOI: 10.1016/j.febslet.2008.08.010] [Cited by in Crossref: 35] [Cited by in F6Publishing: 35] [Article Influence: 2.7] [Reference Citation Analysis]
137 Fontana RJ, Dienstag JL, Bonkovsky HL, Sterling RK, Naishadham D, Goodman ZD, Lok AS, Wright EC, Su GL. Serum fibrosis markers are associated with liver disease progression in non-responder patients with chronic hepatitis C. Gut. 2010;59:1401-1409. [PMID: 20675691 DOI: 10.1136/gut.2010.207423.] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
138 Nielsen AR, Erikstrup C, Johansen JS, Fischer CP, Plomgaard P, Krogh-Madsen R, Taudorf S, Lindegaard B, Pedersen BK. Plasma YKL-40: a BMI-independent marker of type 2 diabetes. Diabetes. 2008;57:3078-3082. [PMID: 18650368 DOI: 10.2337/db08-0182] [Cited by in Crossref: 96] [Cited by in F6Publishing: 97] [Article Influence: 7.4] [Reference Citation Analysis]
139 Thongsom S, Chaocharoen W, Silsirivanit A, Wongkham S, Sripa B, Choe H, Suginta W, Talabnin C. YKL-40/chitinase-3-like protein 1 is associated with poor prognosis and promotes cell growth and migration of cholangiocarcinoma. Tumour Biol. 2016;37:9451-9463. [PMID: 26781979 DOI: 10.1007/s13277-016-4838-z] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 3.8] [Reference Citation Analysis]
140 Loeser RF, Chubinskaya S, Pacione C, Im HJ. Basic fibroblast growth factor inhibits the anabolic activity of insulin-like growth factor 1 and osteogenic protein 1 in adult human articular chondrocytes. Arthritis Rheum 2005;52:3910-7. [PMID: 16320338 DOI: 10.1002/art.21472] [Cited by in Crossref: 80] [Cited by in F6Publishing: 78] [Article Influence: 5.3] [Reference Citation Analysis]
141 Roslind A, Balslev E, Kruse H, Stærgaard B, Horn T. Subcellular Localization of YKL-40 in Normal and Malignant Epithelial Cells of the Breast. Ultrastructural Pathology 2009;32:101-6. [DOI: 10.1080/01913120801937673] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
142 Towler BP, Pashler AL, Haime HJ, Przybyl KM, Viegas SC, Matos RG, Morley SJ, Arraiano CM, Newbury SF. Dis3L2 regulates cell proliferation and tissue growth through a conserved mechanism. PLoS Genet 2020;16:e1009297. [PMID: 33370287 DOI: 10.1371/journal.pgen.1009297] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
143 Roslind A, Knoop AS, Jensen MB, Johansen JS, Nielsen DL, Price PA, Balslev E. YKL-40 protein expression is not a prognostic marker in patients with primary breast cancer. Breast Cancer Res Treat 2008;112:275-85. [PMID: 18157633 DOI: 10.1007/s10549-007-9870-7] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 1.6] [Reference Citation Analysis]
144 Duraković N, Krečak I, Perić Z, Milošević M, Desnica L, Pulanić D, Pusic I, Kušec V, Vrhovac R, Pavletic SZ, Nemet D. Glycoprotein YKL-40: a novel biomarker of chronic graft-vs-host disease activity and severity? Croat Med J 2016;57:239-46. [PMID: 27374825 DOI: 10.3325/cmj.2016.57.239] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
145 Francescone RA, Scully S, Faibish M, Taylor SL, Oh D, Moral L, Yan W, Bentley B, Shao R. Role of YKL-40 in the angiogenesis, radioresistance, and progression of glioblastoma. J Biol Chem. 2011;286:15332-15343. [PMID: 21385870 DOI: 10.1074/jbc.m110.212514] [Cited by in Crossref: 142] [Cited by in F6Publishing: 94] [Article Influence: 14.2] [Reference Citation Analysis]
146 Wang L, Bao A, Zheng Y, Ma A, Wu Y, Shang H, Fang D, Ben S. Adenovirus vector-mediated YKL-40 shRNA attenuates eosinophil airway inflammation in a murine asthmatic model. Gene Ther 2021;28:177-85. [PMID: 33046836 DOI: 10.1038/s41434-020-00202-0] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
147 Johansen JS, Schultz NA, Jensen BV. Plasma YKL-40: a potential new cancer biomarker? Future Oncol 2009;5:1065-82. [PMID: 19792974 DOI: 10.2217/fon.09.66] [Cited by in Crossref: 96] [Cited by in F6Publishing: 106] [Article Influence: 8.0] [Reference Citation Analysis]
148 Deutschmann C, Roggenbuck D, Schierack P. The loss of tolerance to CHI3L1 – A putative role in inflammatory bowel disease? Clinical Immunology 2019;199:12-7. [DOI: 10.1016/j.clim.2018.12.005] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
149 Majewski S, Tworek D, Szewczyk K, Kiszałkiewicz J, Kurmanowska Z, Brzeziańska-Lasota E, Jerczyńska H, Antczak A, Piotrowski WJ, Górski P. Overexpression of chitotriosidase and YKL-40 in peripheral blood and sputum of healthy smokers and patients with chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis 2019;14:1611-31. [PMID: 31413557 DOI: 10.2147/COPD.S184097] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
150 Einarsson JM, Bahrke S, Sigurdsson BT, Ng CH, Petersen PH, Sigurjonsson OE, Jonsson H Jr, Gislason J, Thormodsson FR, Peter MG. Partially acetylated chitooligosaccharides bind to YKL-40 and stimulate growth of human osteoarthritic chondrocytes. Biochem Biophys Res Commun 2013;434:298-304. [PMID: 23541584 DOI: 10.1016/j.bbrc.2013.02.122] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 1.5] [Reference Citation Analysis]
151 Chen XH, Cai GP. Molecular cloning and characterization of rat chitotriosidase. DNA Seq 2008;19:121-9. [PMID: 17852345 DOI: 10.1080/10425170701447499] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
152 Petersson M, Bucht E, Granberg B, Stark A. Effects of arginine-vasopressin and parathyroid hormone-related protein (1–34) on cell proliferation and production of YKL-40 in cultured chondrocytes from patients with rheumatoid arthritis and osteoarthritis. Osteoarthritis and Cartilage 2006;14:652-9. [DOI: 10.1016/j.joca.2006.01.003] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 0.8] [Reference Citation Analysis]
153 Kzhyshkowska J, Krusell L. Cross-talk between endocytic clearance and secretion in macrophages. Immunobiology 2009;214:576-93. [DOI: 10.1016/j.imbio.2009.03.007] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 1.6] [Reference Citation Analysis]
154 Rivas-Alarcón AA, Gómez-Gómez Y, Organista-Nava J, Jiménez-López MA, Rivera-Ramírez AB, Ibarra-Sierra E, Saavedra-Herrera MV, Illades-Aguiar B, Leyva-Vázquez MA. Plasma levels of YKL-40 as a prognostic factor in childhood acute lymphoblastic leukemia. Mol Clin Oncol 2021;15:168. [PMID: 34194746 DOI: 10.3892/mco.2021.2330] [Reference Citation Analysis]
155 Kzhyshkowska J, Mamidi S, Gratchev A, Kremmer E, Schmuttermaier C, Krusell L, Haus G, Utikal J, Schledzewski K, Scholtze J. Novel stabilin-1 interacting chitinase-like protein (SI-CLP) is up-regulated in alternatively activated macrophages and secreted via lysosomal pathway. Blood. 2006;107:3221-3228. [PMID: 16357325 DOI: 10.1182/blood-2005-07-2843] [Cited by in Crossref: 142] [Cited by in F6Publishing: 132] [Article Influence: 8.9] [Reference Citation Analysis]
156 Algarra B, Han L, Soriano-Úbeda C, Avilés M, Coy P, Jovine L, Jiménez-Movilla M. The C-terminal region of OVGP1 remodels the zona pellucida and modifies fertility parameters. Sci Rep 2016;6:32556. [PMID: 27601270 DOI: 10.1038/srep32556] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 3.0] [Reference Citation Analysis]
157 Lieder R, Sigurjonsson OE. The Effect of Recombinant Human Interleukin-6 on Osteogenic Differentiation and YKL-40 Expression in Human, Bone Marrow-Derived Mesenchymal Stem Cells. Biores Open Access 2014;3:29-34. [PMID: 24570843 DOI: 10.1089/biores.2013.0035] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 2.1] [Reference Citation Analysis]
158 Zorzi F, Calabrese E, Monteleone I, Fantini M, Onali S, Biancone L, Pallone F, Monteleone G. A phase 1 open-label trial shows that smad7 antisense oligonucleotide (GED0301) does not increase the risk of small bowel strictures in Crohn’s disease. Aliment Pharmacol Ther 2012;36:850-7. [PMID: 22971085 DOI: 10.1111/apt.12051] [Cited by in Crossref: 43] [Cited by in F6Publishing: 37] [Article Influence: 5.4] [Reference Citation Analysis]
159 Böckelmann LC, Felix T, Calabrò S, Schumacher U. YKL-40 protein expression in human tumor samples and human tumor cell line xenografts: implications for its use in tumor models. Cell Oncol (Dordr) 2021;44:1183-95. [PMID: 34432260 DOI: 10.1007/s13402-021-00630-z] [Reference Citation Analysis]
160 Kruit A, Grutters JC, Ruven HJ, van Moorsel CC, van den Bosch JM. A CHI3L1 gene polymorphism is associated with serum levels of YKL-40, a novel sarcoidosis marker. Respiratory Medicine 2007;101:1563-71. [DOI: 10.1016/j.rmed.2006.12.006] [Cited by in Crossref: 51] [Cited by in F6Publishing: 53] [Article Influence: 3.6] [Reference Citation Analysis]
161 Kanneganti M, Kamba A, Mizoguchi E. Role of chitotriosidase (chitinase 1) under normal and disease conditions. J Epithel Biol Pharmacol 2012;5:1-9. [PMID: 23439988 DOI: 10.2174/1875044301205010001] [Cited by in Crossref: 57] [Cited by in F6Publishing: 59] [Article Influence: 6.3] [Reference Citation Analysis]
162 Schimpl M, Rush CL, Betou M, Eggleston IM, Recklies AD, van Aalten DM. Human YKL-39 is a pseudo-chitinase with retained chitooligosaccharide-binding properties. Biochem J 2012;446:149-57. [PMID: 22742450 DOI: 10.1042/BJ20120377] [Cited by in Crossref: 39] [Cited by in F6Publishing: 21] [Article Influence: 4.3] [Reference Citation Analysis]
163 Kim MN, Lee KE, Hong JY, Heo WI, Kim KW, Kim KE, Sohn MH. Involvement of the MAPK and PI3K pathways in chitinase 3-like 1-regulated hyperoxia-induced airway epithelial cell death. Biochem Biophys Res Commun 2012;421:790-6. [PMID: 22554524 DOI: 10.1016/j.bbrc.2012.04.085] [Cited by in Crossref: 31] [Cited by in F6Publishing: 30] [Article Influence: 3.4] [Reference Citation Analysis]
164 Shao R, Hamel K, Petersen L, Cao QJ, Arenas RB, Bigelow C, Bentley B, Yan W. YKL-40, a secreted glycoprotein, promotes tumor angiogenesis. Oncogene. 2009;28:4456-4468. [PMID: 19767768 DOI: 10.1038/onc.2009.292] [Cited by in Crossref: 168] [Cited by in F6Publishing: 179] [Article Influence: 14.0] [Reference Citation Analysis]
165 Cheng L, Wang Y, He Q, Li H, Zhang X, Zhang F. Comparative proteomics illustrates the complexity of drought resistance mechanisms in two wheat (Triticum aestivum L.) cultivars under dehydration and rehydration. BMC Plant Biol 2016;16:188. [PMID: 27576435 DOI: 10.1186/s12870-016-0871-8] [Cited by in Crossref: 39] [Cited by in F6Publishing: 29] [Article Influence: 7.8] [Reference Citation Analysis]
166 van Golen KL, Ying C, Sequeira L, Dubyk CW, Reisenberger T, Chinnaiyan AM, Pienta KJ, Loberg RD. CCL2 induces prostate cancer transendothelial cell migration via activation of the small GTPase Rac. J Cell Biochem 2008;104:1587-97. [PMID: 18646053 DOI: 10.1002/jcb.21652] [Cited by in Crossref: 36] [Cited by in F6Publishing: 33] [Article Influence: 2.8] [Reference Citation Analysis]
167 Yan L, Deng Y, Zhou J, Zhao H, Wang G; China HepB-Related Fibrosis Assessment Research Group. Serum YKL-40 as a biomarker for liver fibrosis in chronic hepatitis B patients with normal and mildly elevated ALT. Infection 2018;46:385-93. [PMID: 29600444 DOI: 10.1007/s15010-018-1136-2] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 5.7] [Reference Citation Analysis]
168 Esteghamati A, Rezvani S, Khajeh E, Ebadi M, Nakhjavani M, Noshad S. Comparative effects of metformin and pioglitazone on YKL-40 in type 2 diabetes: a randomized clinical trial. J Endocrinol Invest 2014;37:1211-8. [PMID: 25138574 DOI: 10.1007/s40618-014-0154-x] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
169 Berenbaum F. Signaling transduction: target in osteoarthritis: . Current Opinion in Rheumatology 2004;16:616-22. [DOI: 10.1097/01.bor.0000133663.37352.4a] [Cited by in Crossref: 93] [Cited by in F6Publishing: 89] [Article Influence: 5.5] [Reference Citation Analysis]
170 Deutschmann C, Sowa M, Murugaiyan J, Roesler U, Röber N, Conrad K, Laass MW, Bogdanos D, Sipeki N, Papp M, Rödiger S, Roggenbuck D, Schierack P. Identification of Chitinase-3-Like Protein 1 as a Novel Neutrophil Antigenic Target in Crohn's Disease. J Crohns Colitis 2019;13:894-904. [PMID: 30753386 DOI: 10.1093/ecco-jcc/jjz012] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 8.0] [Reference Citation Analysis]
171 Tschirdewahn S, Reis H, Niedworok C, Nyirady P, Szendröi A, Schmid KW, Shariat SF, Kramer G, vom Dorp F, Rübben H, Szarvas T. Prognostic effect of serum and tissue YKL-40 levels in bladder cancer. Urologic Oncology: Seminars and Original Investigations 2014;32:663-9. [DOI: 10.1016/j.urolonc.2014.02.004] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 1.7] [Reference Citation Analysis]
172 Pizano-Martínez O, Yañez-Sánchez I, Alatorre-Carranza P, Miranda-Díaz A, Ortiz-Lazareno PC, García-Iglesias T, Daneri-Navarro A, Mercado MVD, Fafutis-Morris M, Delgado-Rizo V. YKL-40 expression in CD14+ liver cells in acute and chronic injury. World J Gastroenterol 2011; 17(33): 3830-3835 [PMID: 21987626 DOI: 10.3748/wjg.v17.i33.3830] [Cited by in CrossRef: 12] [Cited by in F6Publishing: 15] [Article Influence: 1.2] [Reference Citation Analysis]
173 Yamamori H, Hashimoto R, Ohi K, Yasuda Y, Fukumoto M, Kasahara E, Sekiyama A, Umeda-Yano S, Okada T, Iwase M, Kazui H, Ito A, Takeda M. A promoter variant in the chitinase 3-like 1 gene is associated with serum YKL-40 level and personality trait. Neurosci Lett 2012;513:204-8. [PMID: 22366530 DOI: 10.1016/j.neulet.2012.02.039] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 1.7] [Reference Citation Analysis]
174 Zhang JP, Yuan HX, Kong WT, Liu Y, Lin ZM, Wangs WP, Guo JM. Increased expression of Chitinase 3-like 1 and microvessel density predicts metastasis and poor prognosis in clear cell renal cell carcinoma. Tumour Biol 2014;35:12131-7. [PMID: 25142236 DOI: 10.1007/s13277-014-2518-4] [Cited by in Crossref: 12] [Cited by in F6Publishing: 15] [Article Influence: 1.7] [Reference Citation Analysis]
175 Brasso K, Christensen IJ, Johansen JS, Teisner B, Garnero P, Price PA, Iversen P. Prognostic value of PINP, bone alkaline phosphatase, CTX-I, and YKL-40 in patients with metastatic prostate carcinoma. Prostate 2006;66:503-13. [DOI: 10.1002/pros.20311] [Cited by in Crossref: 80] [Cited by in F6Publishing: 73] [Article Influence: 5.3] [Reference Citation Analysis]
176 Ngernyuang N, Francescone RA, Jearanaikoon P, Daduang J, Supoken A, Yan W, Shao R, Limpaiboon T. Chitinase 3 like 1 is associated with tumor angiogenesis in cervical cancer. Int J Biochem Cell Biol 2014;51:45-52. [PMID: 24691276 DOI: 10.1016/j.biocel.2014.03.021] [Cited by in Crossref: 22] [Cited by in F6Publishing: 26] [Article Influence: 3.1] [Reference Citation Analysis]
177 Kzhyshkowska J, Gratchev A, Goerdt S. Stabilin-1, a homeostatic scavenger receptor with multiple functions. J Cell Mol Med 2006;10:635-49. [PMID: 16989725 DOI: 10.1111/j.1582-4934.2006.tb00425.x] [Cited by in Crossref: 108] [Cited by in F6Publishing: 103] [Article Influence: 7.7] [Reference Citation Analysis]
178 Hector A, Kormann MS, Mack I, Latzin P, Casaulta C, Kieninger E, Zhou Z, Yildirim AÖ, Bohla A, Rieber N, Kappler M, Koller B, Eber E, Eickmeier O, Zielen S, Eickelberg O, Griese M, Mall MA, Hartl D. The chitinase-like protein YKL-40 modulates cystic fibrosis lung disease. PLoS One 2011;6:e24399. [PMID: 21949714 DOI: 10.1371/journal.pone.0024399] [Cited by in Crossref: 32] [Cited by in F6Publishing: 35] [Article Influence: 3.2] [Reference Citation Analysis]
179 Mathiasen AB, Harutyunyan MJ, Jørgensen E, Helqvist S, Ripa R, Gøtze JP, Johansen JS, Kastrup J. Plasma YKL-40 in relation to the degree of coronary artery disease in patients with stable ischemic heart disease. Scandinavian Journal of Clinical and Laboratory Investigation 2011;71:439-47. [DOI: 10.3109/00365513.2011.586470] [Cited by in Crossref: 28] [Cited by in F6Publishing: 28] [Article Influence: 2.8] [Reference Citation Analysis]
180 Ogino K, Tsuneki K, Furuya H. CLONING OF CHITINASE-LIKE PROTEIN1 CDNA FROM DICYEMID MESOZOANS (PHYLUM: DICYEMIDA). Journal of Parasitology 2007;93:1403-15. [DOI: 10.1645/ge-1290.1] [Cited by in Crossref: 3] [Article Influence: 0.2] [Reference Citation Analysis]
181 Ziatabar S, Zepf J, Rich S, Danielson BT, Bollyky PI, Stern R. Chitin, chitinases, and chitin lectins: Emerging roles in human pathophysiology. Pathophysiology 2018;25:253-62. [PMID: 30266339 DOI: 10.1016/j.pathophys.2018.02.005] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 5.3] [Reference Citation Analysis]
182 Shaker OG, Elbaz EM. Possible Prognostic Potential of RANKL and OPG in Metastatic Breast Cancer Egyptian Females. Asian Pac J Cancer Prev 2020;21:355-61. [PMID: 32102511 DOI: 10.31557/APJCP.2020.21.2.355] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
183 Kawada M, Seno H, Kanda K, Nakanishi Y, Akitake R, Komekado H, Kawada K, Sakai Y, Mizoguchi E, Chiba T. Chitinase 3-like 1 promotes macrophage recruitment and angiogenesis in colorectal cancer. Oncogene. 2012;31:3111-3123. [PMID: 22056877 DOI: 10.1038/onc.2011.498] [Cited by in Crossref: 108] [Cited by in F6Publishing: 111] [Article Influence: 10.8] [Reference Citation Analysis]
184 Gözükara İ, Özgür T, Dolapçıoğlu K, Güngören A, Karapınar OS. YKL-40 expression in abnormal invasive placenta cases. J Perinat Med 2017;45:571-5. [PMID: 27977409 DOI: 10.1515/jpm-2016-0208] [Reference Citation Analysis]
185 Cheng KC, Lee JJ, Wang SL, Lin CY, Tseng CT, Lin CS, Liao AT. Elevated plasma YKL-40 level is found in the dogs with cancer and is related to poor prognosis. J Vet Sci 2019;20:e53. [PMID: 31565896 DOI: 10.4142/jvs.2019.20.e53] [Reference Citation Analysis]
186 Baroke E, Gauldie J, Kolb M. New treatment and markers of prognosis for idiopathic pulmonary fibrosis: lessons learned from translational research. Expert Rev Respir Med 2013;7:465-78. [PMID: 24138691 DOI: 10.1586/17476348.2013.838015] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
187 Karwelat D, Schmeck B, Ringel M, Benedikter BJ, Hübner K, Beinborn I, Maisner A, Schulte LN, Vollmeister E. Influenza virus-mediated suppression of bronchial Chitinase-3-like 1 secretion promotes secondary pneumococcal infection. FASEB J 2020;34:16432-48. [PMID: 33095949 DOI: 10.1096/fj.201902988RR] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
188 Park JA, Drazen JM, Tschumperlin DJ. The chitinase-like protein YKL-40 is secreted by airway epithelial cells at base line and in response to compressive mechanical stress. J Biol Chem 2010;285:29817-25. [PMID: 20650887 DOI: 10.1074/jbc.M110.103416] [Cited by in Crossref: 56] [Cited by in F6Publishing: 34] [Article Influence: 5.1] [Reference Citation Analysis]
189 Johansen JS, Bojesen SE, Tybjaerg-Hansen A, Mylin AK, Price PA, Nordestgaard BG. Plasma YKL-40 and total and disease-specific mortality in the general population. Clin Chem 2010;56:1580-91. [PMID: 20798353 DOI: 10.1373/clinchem.2010.146530] [Cited by in Crossref: 50] [Cited by in F6Publishing: 46] [Article Influence: 4.5] [Reference Citation Analysis]
190 Hall SC, Hassis ME, Williams KE, Albertolle ME, Prakobphol A, Dykstra AB, Laurance M, Ona K, Niles RK, Prasad N, Gormley M, Shiboski C, Criswell LA, Witkowska HE, Fisher SJ. Alterations in the Salivary Proteome and N -Glycome of Sjögren’s Syndrome Patients. J Proteome Res 2017;16:1693-705. [DOI: 10.1021/acs.jproteome.6b01051] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
191 Johansen JS, Milman N, Hansen M, Garbarsch C, Price PA, Graudal N. Increased serum YKL-40 in patients with pulmonary sarcoidosis--a potential marker of disease activity? Respir Med. 2005;99:396-402. [PMID: 15763444 DOI: 10.1016/j.rmed.2004.09.016] [Cited by in Crossref: 65] [Cited by in F6Publishing: 67] [Article Influence: 3.8] [Reference Citation Analysis]
192 Shaker OG, Helmy HS. Circulating Bone-related Markers and YKL-40 Versus HER2 and TOPO2a in Bone Metastatic and Nonmetastatic Breast Cancer: Diagnostic Implications. Clin Breast Cancer 2018;18:e321-8. [PMID: 28645722 DOI: 10.1016/j.clbc.2017.05.011] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
193 Ling H, Recklies AD. The chitinase 3-like protein human cartilage glycoprotein 39 inhibits cellular responses to the inflammatory cytokines interleukin-1 and tumour necrosis factor-alpha. Biochem J. 2004;380:651-659. [PMID: 15015934 DOI: 10.1042/bj20040099] [Cited by in Crossref: 172] [Cited by in F6Publishing: 150] [Article Influence: 10.1] [Reference Citation Analysis]
194 Weide B, Allgaier N, Hector A, Forschner A, Leiter U, Eigentler TK, Garbe C, Hartl D. Increased CCL17 serum levels are associated with improved survival in advanced melanoma. Cancer Immunol Immunother 2015;64:1075-82. [PMID: 25990074 DOI: 10.1007/s00262-015-1714-4] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 1.2] [Reference Citation Analysis]
195 Roslind A, Johansen JS, Christensen IJ, Kiss K, Balslev E, Nielsen DL, Bentzen J, Price PA, Andersen E. High serum levels of YKL-40 in patients with squamous cell carcinoma of the head and neck are associated with short survival. Int J Cancer. 2008;122:857-863. [PMID: 17957792 DOI: 10.1002/ijc.23152] [Cited by in Crossref: 29] [Cited by in F6Publishing: 28] [Article Influence: 2.2] [Reference Citation Analysis]
196 Rivera AL, Pelloski CE, Sulman E, Aldape K. Prognostic and Predictive Markers in Glioma and Other Neuroepithelial Tumors. Current Problems in Cancer 2008;32:97-123. [DOI: 10.1016/j.currproblcancer.2008.02.003] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]
197 Rathcke CN, Vestergaard H. YKL-40--an emerging biomarker in cardiovascular disease and diabetes. Cardiovasc Diabetol. 2009;8:61. [PMID: 19930630 DOI: 10.1186/1475-2840-8-61] [Cited by in Crossref: 115] [Cited by in F6Publishing: 115] [Article Influence: 9.6] [Reference Citation Analysis]
198 Nøjgaard C, Høst NB, Christensen IJ, Poulsen SH, Egstrup K, Price PA, Johansen JS. Serum levels of YKL-40 increases in patients with acute myocardial infarction. Coron Artery Dis 2008;19:257-63. [PMID: 18480670 DOI: 10.1097/MCA.0b013e3282f40dd5] [Cited by in Crossref: 72] [Cited by in F6Publishing: 31] [Article Influence: 5.5] [Reference Citation Analysis]
199 Görgens SW, Eckardt K, Elsen M, Tennagels N, Eckel J. Chitinase-3-like protein 1 protects skeletal muscle from TNFα-induced inflammation and insulin resistance. Biochem J 2014;459:479-88. [PMID: 24512683 DOI: 10.1042/BJ20131151] [Cited by in Crossref: 40] [Cited by in F6Publishing: 22] [Article Influence: 5.7] [Reference Citation Analysis]
200 Rath T, Roderfeld M, Güler C, Wenzel C, Graf J, Beitinger F, Roeb E, Zachoval R. YKL-40 and transient elastography, a powerful team to assess hepatic fibrosis. Scandinavian Journal of Gastroenterology 2011;46:1369-80. [DOI: 10.3109/00365521.2011.613949] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 1.9] [Reference Citation Analysis]
201 Furukawa T, Matsui K, Kitano M, Yokoyama Y, Sekiguchi M, Azuma N, Imai Y, Hirota S, Yamanishi K, Sano H. Relationship between YKL-40 and pulmonary arterial hypertension in systemic sclerosis. Modern Rheumatology 2019;29:476-83. [DOI: 10.1080/14397595.2018.1480256] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
202 Trudel G, Recklies A, Laneuville O. Increased expression of chitinase 3-like protein 1 secondary to joint immobility. Clin Orthop Relat Res 2007;456:92-7. [PMID: 17194956 DOI: 10.1097/BLO.0b013e3180307c0a] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
203 Mueller A, O'Rourke J, Grimm J, Guillemin K, Dixon MF, Lee A, Falkow S. Distinct gene expression profiles characterize the histopathological stages of disease in Helicobacter-induced mucosa-associated lymphoid tissue lymphoma. Proc Natl Acad Sci U S A. 2003;100:1292-1297. [PMID: 12552104 DOI: 10.1073/pnas.242741699] [Cited by in Crossref: 76] [Cited by in F6Publishing: 76] [Article Influence: 4.2] [Reference Citation Analysis]
204 Anand V, Jaswal S, Singh S, Kumar S, Jena MK, Verma AK, Yadav ML, Janjanam J, Lotfan M, Malakar D, Dang AK, Mohanty TK, Kaushik JK, Mohanty AK. Functional characterization of Mammary Gland Protein-40, a chitinase-like glycoprotein expressed during mammary gland apoptosis. Apoptosis 2016;21:209-24. [DOI: 10.1007/s10495-015-1196-z] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
205 Bussink AP, van Eijk M, Renkema GH, Aerts JM, Boot RG. The biology of the Gaucher cell: the cradle of human chitinases. Int Rev Cytol 2006;252:71-128. [PMID: 16984816 DOI: 10.1016/S0074-7696(06)52001-7] [Cited by in Crossref: 70] [Cited by in F6Publishing: 34] [Article Influence: 5.0] [Reference Citation Analysis]
206 Hartl D, Lee CG, Da Silva CA, Chupp GL, Elias JA. Novel biomarkers in asthma: chemokines and chitinase-like proteins. Curr Opin Allergy Clin Immunol 2009;9:60-6. [PMID: 19532094 DOI: 10.1097/ACI.0b013e32831f8ee0] [Cited by in Crossref: 44] [Cited by in F6Publishing: 26] [Article Influence: 3.7] [Reference Citation Analysis]
207 Junker N, Johansen JS, Andersen CB, Kristjansen PE. Expression of YKL-40 by peritumoral macrophages in human small cell lung cancer. Lung Cancer. 2005;48:223-231. [PMID: 15829322 DOI: 10.1016/j.lungcan.2004.11.011] [Cited by in Crossref: 81] [Cited by in F6Publishing: 76] [Article Influence: 5.1] [Reference Citation Analysis]
208 Kzhyshkowska J, Gratchev A, Goerdt S. Human Chitinases and Chitinase-Like Proteins as Indicators for Inflammation and Cancer. Biomark�Insights 2007;2:117727190700200. [DOI: 10.1177/117727190700200023] [Cited by in Crossref: 115] [Cited by in F6Publishing: 51] [Article Influence: 28.8] [Reference Citation Analysis]
209 Henningsen KM, Nilsson B, Johansen JS, Chen X, Pehrson S, Svendsen JH. Plasma YKL-40 is elevated in patients with recurrent atrial fibrillation after catheter ablation. Inflamm Res 2010;59:463-9. [PMID: 20012147 DOI: 10.1007/s00011-009-0146-z] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 1.3] [Reference Citation Analysis]
210 Brøchner CB, Johansen JS, Larsen LA, Bak M, Mikkelsen HB, Byskov AG, Andersen CY, Møllgård K. YKL-40 is differentially expressed in human embryonic stem cells and in cell progeny of the three germ layers. J Histochem Cytochem 2012;60:188-204. [PMID: 22140133 DOI: 10.1369/0022155411433331] [Cited by in Crossref: 33] [Cited by in F6Publishing: 30] [Article Influence: 3.3] [Reference Citation Analysis]
211 Burmester GR, Weinblatt ME, McInnes IB, Porter D, Barbarash O, Vatutin M, Szombati I, Esfandiari E, Sleeman MA, Kane CD, Cavet G, Wang B, Godwood A, Magrini F; EARTH Study Group. Efficacy and safety of mavrilimumab in subjects with rheumatoid arthritis. Ann Rheum Dis 2013;72:1445-52. [PMID: 23234647 DOI: 10.1136/annrheumdis-2012-202450] [Cited by in Crossref: 122] [Cited by in F6Publishing: 115] [Article Influence: 13.6] [Reference Citation Analysis]
212 Tsai ML, Liaw SH, Chang NC. The crystal structure of Ym1 at 1.31 A resolution. J Struct Biol 2004;148:290-6. [PMID: 15522777 DOI: 10.1016/j.jsb.2004.07.002] [Cited by in Crossref: 24] [Cited by in F6Publishing: 22] [Article Influence: 1.5] [Reference Citation Analysis]
213 Rani R, Singh V. Overexpression of YKL-40 (CHI3L1 gene) in patient fluids may be a potential predictive marker for early detection of comorbidity in non-communicable disease. Med Hypotheses 2020;143:110076. [PMID: 32721792 DOI: 10.1016/j.mehy.2020.110076] [Reference Citation Analysis]
214 van der Ploeg EA, Melgert BN, Burgess JK, Gan CT. The potential of biomarkers of fibrosis in chronic lung allograft dysfunction. Transplant Rev (Orlando) 2021;35:100626. [PMID: 33992914 DOI: 10.1016/j.trre.2021.100626] [Reference Citation Analysis]
215 Kang EJ, Jung H, Woo OH, Park KH, Woo SU, Yang DS, Kim AR, Lee JB, Kim YH, Kim JS, Seo JH. YKL-40 expression could be a poor prognostic marker in the breast cancer tissue. Tumour Biol 2014;35:277-86. [PMID: 23918300 DOI: 10.1007/s13277-013-1036-0] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 1.6] [Reference Citation Analysis]
216 Castellani RJ, Perry G, Smith MA. The role of novel chitin-like polysaccharides in Alzheimer disease. Neurotox Res 2007;12:269-74. [PMID: 18201954 DOI: 10.1007/BF03033910] [Cited by in Crossref: 23] [Cited by in F6Publishing: 11] [Article Influence: 1.8] [Reference Citation Analysis]
217 Fettke A, Peikow D, Peter MG, Kleinpeter E. Synthesis and conformational analysis of glycomimetic analogs of thiochitobiose. Tetrahedron 2009;65:4356-66. [DOI: 10.1016/j.tet.2009.03.067] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 1.1] [Reference Citation Analysis]
218 Lieder R, Thormodsson F, Ng CH, Einarsson JM, Gislason J, Petersen PH, Sigurjonsson OE. Chitosan and Chitin Hexamers affect expansion and differentiation of mesenchymal stem cells differently. Int J Biol Macromol 2012;51:675-80. [PMID: 22790025 DOI: 10.1016/j.ijbiomac.2012.07.005] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 1.4] [Reference Citation Analysis]
219 Pérez-García S, Calamia V, Hermida-Gómez T, Gutiérrez-Cañas I, Carrión M, Villanueva-Romero R, Castro D, Martínez C, Juarranz Y, Blanco FJ, Gomariz RP. Proteomic Analysis of Synovial Fibroblasts and Articular Chondrocytes Co-Cultures Reveals Valuable VIP-Modulated Inflammatory and Degradative Proteins in Osteoarthritis. Int J Mol Sci 2021;22:6441. [PMID: 34208590 DOI: 10.3390/ijms22126441] [Reference Citation Analysis]
220 Zhao X, Tang R, Gao B, Shi Y, Zhou J, Guo S, Zhang J, Wang Y, Tang W, Meng J, Li S, Wang H, Ma G, Lin C, Xiao Y, Feng G, Lin Z, Zhu S, Xing Y, Sang H, St Clair D, He L. Functional variants in the promoter region of Chitinase 3-like 1 (CHI3L1) and susceptibility to schizophrenia. Am J Hum Genet 2007;80:12-8. [PMID: 17160890 DOI: 10.1086/510438] [Cited by in Crossref: 59] [Cited by in F6Publishing: 60] [Article Influence: 3.9] [Reference Citation Analysis]
221 Shi L, Paskewitz SM. Identification and molecular characterization of two immune-responsive chitinase-like proteins from Anopheles gambiae. Insect Mol Biol 2004;13:387-98. [PMID: 15271211 DOI: 10.1111/j.0962-1075.2004.00496.x] [Cited by in Crossref: 37] [Cited by in F6Publishing: 37] [Article Influence: 2.2] [Reference Citation Analysis]
222 Morera E, Steinhäuser SS, Budkova Z, Ingthorsson S, Kricker J, Krueger A, Traustadottir GA, Gudjonsson T. YKL-40/CHI3L1 facilitates migration and invasion in HER2 overexpressing breast epithelial progenitor cells and generates a niche for capillary-like network formation. In Vitro Cell Dev Biol Anim 2019;55:838-53. [PMID: 31482369 DOI: 10.1007/s11626-019-00403-x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
223 Bigg HF, Wait R, Rowan AD, Cawston TE. The mammalian chitinase-like lectin, YKL-40, binds specifically to type I collagen and modulates the rate of type I collagen fibril formation. J Biol Chem 2006;281:21082-95. [PMID: 16704970 DOI: 10.1074/jbc.M601153200] [Cited by in Crossref: 99] [Cited by in F6Publishing: 38] [Article Influence: 6.6] [Reference Citation Analysis]
224 Barksby HE, Hui W, Wappler I, Peters HH, Milner JM, Richards CD, Cawston TE, Rowan AD. Interleukin-1 in combination with oncostatin M up-regulates multiple genes in chondrocytes: Implications for cartilage destruction and repair. Arthritis Rheum 2006;54:540-50. [DOI: 10.1002/art.21574] [Cited by in Crossref: 61] [Cited by in F6Publishing: 64] [Article Influence: 4.1] [Reference Citation Analysis]
225 Li F, Sheng Z, Lan H, Xu J, Li J. Downregulated CHI3L1 alleviates skeletal muscle stem cell injury in a mouse model of sepsis. IUBMB Life 2020;72:214-25. [PMID: 31463997 DOI: 10.1002/iub.2156] [Reference Citation Analysis]
226 Fusetti F, Pijning T, Kalk KH, Bos E, Dijkstra BW. Crystal structure and carbohydrate-binding properties of the human cartilage glycoprotein-39. J Biol Chem. 2003;278:37753-37760. [PMID: 12851408 DOI: 10.1074/jbc.m303137200] [Cited by in Crossref: 132] [Cited by in F6Publishing: 63] [Article Influence: 7.3] [Reference Citation Analysis]
227 Zhang W, Kawanishi M, Miyake K, Kagawa M, Kawai N, Murao K, Nishiyama A, Fei Z, Zhang X, Tamiya T. Association between YKL-40 and adult primary astrocytoma. Cancer 2010;116:2688-97. [PMID: 20499402 DOI: 10.1002/cncr.25084] [Cited by in Crossref: 5] [Cited by in F6Publishing: 12] [Article Influence: 0.5] [Reference Citation Analysis]
228 Rieder F, Latella G, Magro F, Yuksel ES, Higgins PDR, Di Sabatino A, de Bruyn JR, Rimola J, Brito J, Bettenworth D, van Assche G, Bemelman W, d’Hoore A, Pellino G, Dignass AU. European Crohn’s and Colitis Organisation Topical Review on Prediction, Diagnosis and Management of Fibrostenosing Crohn’s Disease. ECCOJC 2016;10:873-85. [DOI: 10.1093/ecco-jcc/jjw055] [Cited by in Crossref: 102] [Cited by in F6Publishing: 92] [Article Influence: 20.4] [Reference Citation Analysis]
229 Capone M, Maggi L, Santarlasci V, Rossi MC, Mazzoni A, Montaini G, Cimaz R, Ramazzotti M, Piccinni MP, Barra G, De Palma R, Liotta F, Maggi E, Romagnani S, Annunziato F, Cosmi L. Chitinase 3-like-1 is produced by human Th17 cells and correlates with the level of inflammation in juvenile idiopathic arthritis patients. Clin Mol Allergy 2016;14:16. [PMID: 27826220 DOI: 10.1186/s12948-016-0053-0] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
230 Komabashiri N, Suehiro F, Ishii M, Nishimura M. Efficacy of chitinase-3-like protein 1 as an in vivo bone formation predictable marker of maxillary/mandibular bone marrow stromal cells. Regen Ther 2021;18:38-50. [PMID: 33869686 DOI: 10.1016/j.reth.2021.03.004] [Reference Citation Analysis]
231 Libreros S, Garcia-Areas R, Iragavarapu-Charyulu V. CHI3L1 plays a role in cancer through enhanced production of pro-inflammatory/pro-tumorigenic and angiogenic factors. Immunol Res. 2013;57:99-105. [PMID: 24222276 DOI: 10.1007/s12026-013-8459-y] [Cited by in Crossref: 56] [Cited by in F6Publishing: 59] [Article Influence: 8.0] [Reference Citation Analysis]
232 Korthagen NM, van Moorsel CHM, Zanen P, Ruven HJ, Grutters JC. Evaluation of Circulating YKL-40 Levels in Idiopathic Interstitial Pneumonias. Lung 2014;192:975-80. [DOI: 10.1007/s00408-014-9647-9] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 3.4] [Reference Citation Analysis]
233 Zimmerman SG, Merrihew GE, MacCoss MJ, Berg CA. Proteomics Analysis Identifies Orthologs of Human Chitinase-Like Proteins as Inducers of Tube Morphogenesis Defects in Drosophila melanogaster. Genetics 2017;206:973-84. [PMID: 28404605 DOI: 10.1534/genetics.116.199323] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
234 Areshkov PA, Kavsan VM. Chitinase 3-like protein 2 (CHI3L2, YKL-39) activates phosphorylation of extracellular signal-regulated kinases ERK1/ERK2 in human embryonic kidney (HEK293) and human glioblastoma (U87 MG) cells. Cytol Genet 2010;44:1-6. [DOI: 10.3103/s0095452710010019] [Cited by in Crossref: 5] [Article Influence: 0.5] [Reference Citation Analysis]
235 Johansen JS, Christensen IJ, Riisbro R, Greenall M, Han C, Price PA, Smith K, Brünner N, Harris AL. High serum YKL-40 levels in patients with primary breast cancer is related to short recurrence free survival. Breast Cancer Res Treat 2003;80:15-21. [PMID: 12889595 DOI: 10.1023/A:1024431000710] [Cited by in Crossref: 88] [Cited by in F6Publishing: 47] [Article Influence: 4.9] [Reference Citation Analysis]
236 Saleh AA, Alhanafy AM, Elbahr O, El-hefnawy SM. Chitinase 3-like 1 gene (T/C) polymorphism and serum YKL-40 levels in patients with hepatocellular carcinoma. Meta Gene 2020;24:100686. [DOI: 10.1016/j.mgene.2020.100686] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
237 Hübner K, Karwelat D, Pietsch E, Beinborn I, Winterberg S, Bedenbender K, Benedikter BJ, Schmeck B, Vollmeister E. NF-κB-mediated inhibition of microRNA-149-5p regulates Chitinase-3-like 1 expression in human airway epithelial cells. Cell Signal 2020;67:109498. [PMID: 31837465 DOI: 10.1016/j.cellsig.2019.109498] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
238 Hansen M, Nielsen AR, Vilsbøll T, Lund A, Krarup T, Knop FK, Vestergaard H. Increased levels of YKL-40 and interleukin 6 in patients with chronic pancreatitis and secondary diabetes. Pancreas. 2012;41:1316-1318. [PMID: 22647735 DOI: 10.1097/mpa.0b013e31824d9b93] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
239 Colton CA. Heterogeneity of microglial activation in the innate immune response in the brain. J Neuroimmune Pharmacol 2009;4:399-418. [PMID: 19655259 DOI: 10.1007/s11481-009-9164-4] [Cited by in Crossref: 532] [Cited by in F6Publishing: 523] [Article Influence: 44.3] [Reference Citation Analysis]
240 Zhou Y, Peng H, Sun H, Peng X, Tang C, Gan Y, Chen X, Mathur A, Hu B, Slade MD, Montgomery RR, Shaw AC, Homer RJ, White ES, Lee CM, Moore MW, Gulati M, Lee CG, Elias JA, Herzog EL. Chitinase 3-like 1 suppresses injury and promotes fibroproliferative responses in Mammalian lung fibrosis. Sci Transl Med 2014;6:240ra76. [PMID: 24920662 DOI: 10.1126/scitranslmed.3007096] [Cited by in Crossref: 97] [Cited by in F6Publishing: 93] [Article Influence: 16.2] [Reference Citation Analysis]
241 Kim MH, Wu WH, Choi JH, Kim J, Jun JH, Ko Y, Lee JH. Galectin-1 from conditioned medium of three-dimensional culture of adipose-derived stem cells accelerates migration and proliferation of human keratinocytes and fibroblasts. Wound Repair Regen 2018;26 Suppl 1:S9-S18. [PMID: 28857355 DOI: 10.1111/wrr.12579] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 4.3] [Reference Citation Analysis]
242 Eurich K, Segawa M, Toei-Shimizu S, Mizoguchi E. Potential role of chitinase 3-like-1 in inflammation-associated carcinogenic changes of epithelial cells. World J Gastroenterol 2009; 15(42): 5249-5259 [PMID: 19908331 DOI: 10.3748/wjg.15.5249] [Cited by in CrossRef: 55] [Cited by in F6Publishing: 56] [Article Influence: 4.6] [Reference Citation Analysis]
243 Salamon J, Hoffmann T, Elies E, Peldschus K, Johansen JS, Lüers G, Schumacher U, Wicklein D. Antibody directed against human YKL-40 increases tumor volume in a human melanoma xenograft model in scid mice. PLoS One 2014;9:e95822. [PMID: 24752554 DOI: 10.1371/journal.pone.0095822] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.7] [Reference Citation Analysis]